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Health care providers use laboratory test 
results to diagnose disease, determine 
prognosis, and monitor a patient’s treatment 
or health status. Current practice shows an 
increased trend for medical decisions based 
on tests performed at the point of care. 
Forethought, planning, and preparation 
are critical when making decisions to begin 
testing or when adding a new test to the 
menu in a laboratory, physician office, or 
other point-of-care location. The Clinical 
Laboratory Improvement Amendments of 
1988 (CLIA) Certificate for Provider-Performed 
Microscopy (PPM) procedures issued by the 
Centers for Medicare & Medicaid Services 
(CMS) permits a laboratory or testing site to 
perform a limited list of moderate complexity 
microscopic tests, as well as any waived tests. 
PURPOSE
PPM-certified laboratories may perform certain microscopic examinations during the course of a 
patient visit using specimens that quickly deteriorate or are not easily transportable. PPM-certified 
laboratories must meet the same CLIA quality standards as laboratories performing moderate 
complexity tests. This booklet describes recommended practices for physicians, midlevel 
practitioners (nurse midwife, nurse practitioner, or physician assistant), and dentists who perform 
patient testing under a CLIA Certificate for PPM procedures. The CLIA requirements for testing 
under a Certificate for PPM can be found at http://www.gpo.gov/fdsys/pkg/CFR-2003-title42-vol3/
xml/CFR-2003-title42-vol3-part493.xml#seqnum493.19. 
Although some of the recommendations in this booklet exceed CLIA requirements for 
provider-performed microscopy testing, following these good testing practices will likely lead 
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Regulatory Requirements — 1
Regulatory Requirements
OVERVIEW
Provider-performed microscopy (PPM) procedures are a select group of moderately complex 
microscopy tests commonly performed by health care providers during patient office visits. 
Tests included in PPM procedures do not meet the criteria for waiver because they are not 
simple procedures; they require training and specific skills for test performance. A CLIA 
Certificate for PPM procedures allows physicians, midlevel practitioners, and dentists to 
perform certain moderate complexity microscopic examinations in addition to waived testing 
during a patient’s visit. Controls are generally not available to monitor the complete testing 
process for these procedures. Therefore, only limited activities are suitable for inspection. 
The laboratory or testing site performing PPM procedures is not subject to routine biennial 
inspections. However, a CLIA certificate is required and the laboratory or testing site must 
meet the CLIA quality standards for moderate complexity testing. 
PROVIDER-PERFORMED MICROSCOPY PROCEDURES
The moderate complexity PPM procedures are performed by a health care provider during 
a patient visit in the context of a physical examination. Limited specimen handling or 
processing is required and the specimen is labile or delay in performing the test could 
compromise the accuracy of the test result, and control materials are not available to monitor 
the entire testing process.
The PPM-certified testing site is restricted to 
nine specific microscopic examinations using 
bright-field or phase-contrast microscopy: 
99 All direct wet mount preparations for the 
presence or absence of bacteria, fungi, 
parasites, and human cellular elements
99 All potassium hydroxide (KOH) preparations
99 Pinworm examinations
99 Fern tests
99 Post-coital direct, qualitative examinations 
of vaginal or cervical mucous
99 Urine sediment examinations
99 Nasal smears for granulocytes
99 Fecal leukocyte examinations
99 Qualitative semen analysis (limited to 
the presence or absence of sperm and 
detection of motility)
Under PPM, the testing site may also perform 
all waived tests.
2 — Regulatory Requirements
CLIA CERTIFICATE FOR PROVIDER-PERFORMED 
MICROSCOPY PROCEDURES 
Obtaining a CLIA Certificate for PPM Procedures
Before testing patient specimens, federal 
regulations require testing sites to have a CLIA 
certificate issued by CMS. Sites performing PPM 
procedures must file for a Certificate for PPM 
procedures and obtain a separate certificate for 
each location.
To obtain a CLIA Certificate for PPM procedures, 
complete the CMS-116 form found at:  
https://www.cms.gov/Medicare/CMS-Forms/
CMS-Forms/downloads/cms116.pdf. 
The CMS-116 form must 
99 be signed by an owner or the laboratory director who attests that the laboratory or testing 
site will be operated in accordance with the requirements established by CLIA. 
99 describe the characteristics of the operation and the examinations and other test 
procedures performed including:
 • the name and total number of test procedures and examinations performed annually 
(excluding tests for quality control, quality assurance or proficiency testing purposes); 
 • the methodologies for each test procedure or examination performed, or both; 
 • the qualifications (educational background, training, and experience) of the personnel 
directing and supervising the laboratory or testing site and performing the examinations 
and test procedures.
Send your completed CMS-116 form to the address of the local State Agency for the state in 
which your testing site resides. You should contact this State Agency for additional forms that 
are needed to complete the registration process. Additionally, the CLIA contact in the Regional 
Office may provide assistance. The list of CMS State Agency & Regional Office CLIA Contacts 
can be found at http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/Downloads/
CLIASA.pdf. 
For additional information on how to obtain a Certificate for PPM procedures, refer to the CMS 
brochure located online at http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/
Downloads/HowObtainCLIACertificate.pdf. 
Once your site has obtained a CLIA Certificate for PPM procedures, requirements for testing 
include:
99 Pay the certificate renewal fee every two years.
99 Notify your State Agency of any changes in the laboratory’s ownership, name, address, 
or director within 30 days, or if you wish to add tests that are not categorized as PPM 
procedures or waived.
99 Allow announced or unannounced on-site inspections by a CMS representative.
Regulatory Requirements — 3
Personnel
The laboratory director must possess a current license as a laboratory director issued by the state 
in which the laboratory or testing site is located, if the licensing is required and must be either a
 ● physician (Medical Doctor, Doctor of Osteopathy, or Doctor of Podiatric Medicine)
 ● midlevel practitioner (nurse midwife, nurse practitioner, or physician assistant), or
 ● dentist (Doctor of Dental Surgery or Doctor of Dental Medicine). 
Facility Administration
PPM testing needs to be performed in a location with adequate space, an appropriate physical 
environment, and accommodations for proper disposal of biohazardous waste. The testing site 
must have appropriate and sufficient equipment, instruments, reagents, materials, and supplies 
for the type and volume of testing it performs. Safety procedures must be established, accessible, 
and observed to ensure protection. The testing site must retain its records and, as applicable, 
slides for easy retrieval of information, and must be in compliance with applicable federal, state, 
and local laboratory requirements.
Participation in Proficiency Testing
Moderate complexity tests are subject to participation 
in proficiency testing (PT). While PT is not specifically 
required for PPM procedures, each laboratory or 
testing site must meet the general CLIA requirements 
for alternative performance assessment by verifying 
the accuracy of their testing procedures at least twice 
per year. Several CLIA-approved PT programs offer 
voluntary modules for PPM and participation in a 
clinical microscopy or PPM PT module will satisfy the 
bi-annual alternative performance assessment requirement. If laboratories or testing sites enroll in 
PT, they are subject to all of the requirements for PT including the prohibition of PT referral. 
Quality System
Every testing site that performs PPM testing must establish and maintain written policies and 
procedures for a quality system that covers all phases of the total testing process. The quality 
system needs to include an ongoing quality assessment component that monitors, identifies, 
evaluates, and resolves problems as appropriate for PPM testing. 
Inspection
Although not routinely done, CMS will inspect PPM sites under certain circumstances such as:
 ● if a complaint is made,
 ● to determine if the testing site is performing tests not permitted with a Certificate for PPM,
 ● if there is a risk of harm to a patient due to inaccurate testing, and
 ● to collect information about PPM procedures.
Enforcement
If the testing site fails to comply with the applicable CLIA requirements, CMS may impose 
alternative and/or principal sanctions. Alternative sanctions include directed plan of correction, 
directed portion of a plan of correction, state onsite monitoring, and civil money penalty. Principal 
sanctions include suspension, limitation, or revocation of the PPM Certificate. In addition, failure 
to meet the CLIA requirements may result in suspension of all or part of payments under Medicare 
and Medicaid. The overall compliance history of the laboratory or testing site as well as the nature, 
severity and duration of the deficiencies will be considered when choosing sanctions.
4 — Regulatory Requirements
PERFORMING WAIVED TESTING UNDER A CERTIFICATE 
FOR PPM PROCEDURES
Testing sites with a CLIA Certificate for PPM procedures may also perform waived testing. Waived 
tests include test systems cleared by the Food and Drug Administration (FDA) for home use and 
those tests approved for waiver under CLIA criteria. The FDA list of waived tests is continuously 
being updated. The most current information on FDA-cleared waived tests for verification that the 
test(s) performed by your laboratory or testing site is categorized as waived can be found at the 
following website: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfClia/testswaived.cfm 
Requirements for performing waived testing include: 
 ● Follow the current manufacturer’s instructions for the waived tests you perform, without  
any changes. 
 ● Pay the certificate renewal fee every two years. 
 ● Notify your State Agency of any changes in ownership, name, address, or director within  
30 days, or if you wish to add tests that are not waived. 
 ● Allow announced or unannounced on-site inspections by a CMS representative.
Free educational products are available describing good laboratory practices for waived testing. 
These materials can be found at http://wwwn.cdc.gov/clia/Resources/WaivedTests/default.aspx: 
 ● The “READY? SET? TEST!” booklet describes 
recommended practices for physicians, 
nurses, medical assistants, pharmacists, and 
others who perform patient testing under a 
CLIA Certificate of Waiver. A Spanish version 
is also available.
 ● The “READY? SET? TEST!” poster lists ten 
good practices for testing. A Spanish 
version is also available.
 ● The “READY? SET? TEST!” online training 
provides scenario based training on 
recommended practices for waived testing 
and offers continuing education credit.
 ● The To Test or Not to Test? booklet describes 
considerations and preparations needed 
prior to performing waived testing and 
may assist those who want to implement 
and oversee waived testing or offer a new 
test under a CLIA Certificate of Waiver. 
The booklet contains tips, reminders, and 
resources along with forms and examples 
for use in your testing site. A Spanish 
version is also available.
Regulatory Requirements — 5
STATE AND LOCAL REQUIREMENTS
State and local jurisdictions vary in how they regulate laboratory testing. Some have requirements 
governing testing, personnel licensure, or phlebotomy. Often there are specific regulations for 
biohazard safety or the handling and disposal of medical waste. The person overseeing testing 
should ensure that all state and local requirements are met. When state, local, and federal 
requirements are not the same, follow the strictest requirement that applies to your site.
CONFIDENTIALITY AND PATIENT PRIVACY
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) addresses the privacy 
rights and protection of personal health information. Testing sites are required to establish 
policies and procedures to protect the confidentiality of health and personal information about 
their patients, including patient identification, test results, and all records of testing throughout 
the entire testing process. Several states have medical privacy laws that apply to testing sites. All 
personnel should receive training on maintaining the confidentiality of patient information. Refer 
to the following link for more information on HIPAA: http://www.hhs.gov/ocr/privacy/ 




PPM testing must be personally performed by a health care provider during a patient visit within 
the context of a physical examination. The testing personnel are responsible for specimen 
processing, test performance, and for reporting test results. 
PPM TESTING PERSONNEL 
The health care provider performing testing under a CLIA Certificate for PPM procedures must 
meet one of the following requirements: 
 ● Physician—The physician is a doctor of medicine, 
doctor of osteopathy, or doctor of podiatric 
medicine who is licensed by the state to practice 
medicine, osteopathy, or podiatry within the state 
in which the laboratory or testing site is located. 
The physician may perform testing on specimens 
obtained from his or her patient or the patient of 
another physician or midlevel practitioner in his or 
her group medical practice during the patient’s visit.
 ● Midlevel practitioner—A midlevel practitioner is a nurse midwife, nurse practitioner, or 
physician assistant who is licensed by the state in which the laboratory or testing site is located 
if such licensing is required. A midlevel practitioner may perform PPM procedures either under 
the supervision of a physician or on their own patient or the patient of a clinic, group medical 
practice, or other health care provider in which the midlevel practitioner is a member, or may 
perform PPM procedures in independent practice if authorized by the state. 
 ● Dentist—Dentist means a doctor of dental medicine or doctor of dental surgery who is 
licensed by the state to practice dentistry within the state in which the laboratory or testing 
site is located. The dentist may perform testing on specimens obtained from his or her patient 
or the patient of his or her group dental practice during the patient’s visit.
CLIA REQUIREMENTS FOR PERSONNEL
The CLIA personnel requirements for performing PPM procedures include requirements for a 
laboratory director and testing personnel. A single qualified individual may serve in both roles. 
Testing personnel are responsible for specimen processing, test performance, and result reporting. 
The laboratory director provides overall management and direction and therefore must be 
qualified to manage and direct the testing personnel and the performance of PPM procedures. 
 ● The laboratory director must also be eligible to be an operator of a laboratory or testing site 
within the requirements of CLIA.
 ● The laboratory director must possess a current license as a laboratory director issued by the 
state in which the laboratory or testing site is located, if the licensing is required.
 ● The laboratory director must be authorized to practice independently in the state in which  
the laboratory or testing site is located.
 ● The laboratory director is responsible for the overall operation and administration of  
the laboratory or testing site including the prompt, accurate, and proficient reporting of  
test results.
 ● The laboratory director must direct no more than five laboratories.
 ● The laboratory director must be a physician, a midlevel practitioner, or a dentist.
 ● The laboratory director must ensure that PPM procedures are personally performed by a 
qualified individual and performed in accordance with applicable requirements.
Personnel — 7
TRAINING
Well-trained, skilled personnel are essential for quality testing and patient care. In addition to 
meeting the education requirements, PPM testing personnel should receive adequate training 
before they perform testing and report patient results.
A qualified person should have knowledge of:
99microscope use and maintenance
99 accurate performance of the test(s)
99 good laboratory practices, and
99 safety practices, such as:
 • universal precautions,
 • handling hazardous waste, and
 • appropriate use of personal protective 
equipment (PPE).
The Centers for Disease Control and 
Prevention (CDC) Laboratory Training website 
(http://www.cdc.gov/labtraining/) offers 
numerous online training courses for the 
public health and clinical laboratory 
community free of charge. These courses may 
assist PPM testing personnel and laboratory 
directors in addressing their training needs 
and obtaining continuing education (CE) 
credits needed for maintenance of 
certifications. For example, a basic 
microbiology curriculum series is available that includes a course on basic microscopy 
providing basic knowledge and understanding of the components, setup, procedures, and 
care and maintenance of a bright-field (compound) microscope. This and many other CDC 
Laboratory Training courses are provided through CDC TRAIN, which is an online learning 
management system and an affiliate of the Public Health Foundation TrainingFinder Real-time 
Affiliate Integrated Network (TRAIN). CDC TRAIN (https://cdc.train.org) functions as a gateway 
to a comprehensive catalog of learning products available to learners across the public health 
community including public health practitioners, healthcare professionals, laboratorians, 
epidemiologists, veterinarians, first responders, educators, and students. 
In addition, a well-designed checklist can serve as a guide allowing employees to work 
through the training agenda at their own pace. Feedback on the training provides valuable 
information to employers seeking to improve or identify gaps in their training programs.
See Appendix B for an example Training Checklist and Appendix C for an example Training 
Evaluation form.
Additional training and educational materials may be available from: 
 ● manufacturers and distributors,
 ● professional organizations, and 
 ● state health departments or other government agencies. 
8 — Personnel
COMPETENCY ASSESSMENTS 
Competency is the ability of personnel to apply their skill, knowledge, and experience to perform 
their duties correctly. Competency assessment is used to ensure that the testing personnel are 
fulfilling their duties as required by applicable federal, state, and local requirements. To make 
sure testing is consistent and accurate, the laboratory director should periodically check the 
competency of testing personnel and provide additional training when needed. 
PPM testing personnel are required to undergo competency assessment to ensure accurate 
and reliable testing and reporting. If the laboratory director is the only individual testing and 
reporting test results, a minimum level of proficiency must be established and documented in 
order to ensure that the required competency for accurate and reliable testing and reporting is 
maintained. A common method to establish competency is to participate in external assessment 
activities such as PT. The requirements for performing the assessment and its frequency are 
determined by laboratory or testing site policy and procedure and must be performed for testing 
personnel for each test that the individual is approved to perform. 
The following six procedures are the minimum regulatory requirements for assessment of 
competency for all personnel performing testing: 
1. Direct observations of routine patient test performance, including patient preparation,  
if applicable, specimen handling, processing and testing;
2. Monitoring the recording and reporting of test results;
3. Review of intermediate test results or worksheets, QC records, PT results, and preventive 
maintenance records;
4. Direct observations of performance of instrument maintenance and function checks;
5. Assessment of test performance through testing previously analyzed specimens, internal 
blind testing samples or external PT samples; and
6. Assessment of problem solving skills.
Competency assessment for PPM may include:
 ● observing routine patient test performance, including specimen handling, processing,  
and testing,
 ● monitoring the recording and reporting of results according to the laboratory’s or testing 
site’s procedure,
 ● reviewing testing documents such as worksheets, QC records, PT results, and corrective 
action records,
 ● observing microscope cleaning and maintenance procedures,
 ● monitoring the number of procedural failures,
 ● checking documents for accuracy and completeness, 
 ● participating in external assessment activities such as PT programs, and
 ● monitoring the number of PT failures.
See Appendix D for an example Competency and Performance Assessment form.
CMS provides a brochure providing additional information on competency assessment. “What Do 
I Need to Do to Assess Personnel Competency?” http://www.cms.gov/Regulations-and-Guidance/
Legislation/CLIA/Downloads/CLIA_CompBrochure_508.pdf 
Safety — 9
FEDERAL REGULATIONS FOR SAFETY
The Occupational Safety and Health Administration (OSHA) requires employers to provide a safe 
and healthy workplace for employees. Each site must comply with OSHA standards including:
 ● Comply with OSHA standards to assure the safety and health of employees. OSHA provides 
a list of regulations that normally apply to medical and dental offices in a brochure, Medical 
& Dental Offices—A Guide to Compliance with OSHA Standards: https://www.osha.gov/
Publications/osha3187.pdf 
 ● Treat all human blood and certain human 
body fluids as if they are infectious. 
Strictly enforce the use of universal 
precautions and compliance with 
the bloodborne pathogens standard 
provided at: https://www.osha.gov/SLTC/
bloodbornepathogens/index.html 
 ● Ensure use of personal protective 
equipment (PPE) such as gloves, protective 
coats or gowns, and protective eyewear. 
See OSHA’s PPE Fact Sheet: https://www.
osha.gov/OshDoc/data_General_Facts/
ppe-factsheet.pdf 
 ● Implement a sharps injury prevention 
program. CDC provides a Workbook for 
Designing, Implementing, and Evaluating 
a Sharps Injury Prevention Program: 
http://www.cdc.gov/sharpssafety/pdf/
sharpsworkbook_2008.pdf 
 ● Consider the need for Material Safety Data Sheets (MSDS), site specific Hazardous 
Communications Act training, Chemical Hygiene plan, and mechanism for hazardous 
chemical disposal of stains and alcohols.
 ● Offer hepatitis B vaccination for employees with possible occupational exposure.
 ● Provide safety training to employees on handling blood and other infectious materials.
 ● Provide equipment for safely handling and disposing of biohazardous waste.
 ● Provide a first aid kit and eyewash station. 
 ● Have a written plan for exposure control. See an example: https://www.osha.gov/SLTC/
etools/hospital/hazards/tb/sampleexposurecontrolplan.html 
 ● Maintain records of occupational injuries and illnesses. OSHA provides recordkeeping and 
reporting requirements: https://www.osha.gov/recordkeeping/index.html 
Additional safety practices when performing testing are:
 ● No eating, drinking, or applying makeup in areas where specimens are collected and where 
testing is performed.
 ● Do not store food in refrigerators where testing supplies or specimens are stored.
 ● Have sinks for hand-washing or antiseptic hand washing solutions available.
 ● Post safety information for employees and patients.




Development of a site-specific safety plan that describes policies, procedures, and work practices 
for employee safety provides testing personnel and staff protection from the health hazards that 
may be involved in testing. Accreditation organizations may have additional safety requirements.
See Appendix F for examples of a Safety Plan, Safety Training Checklist, and Incident Report.
STATE REGULATIONS FOR SAFETY
Many states have Occupational Safety and Health (OSH) Plans that are monitored by OSHA. If you 
live in a state that provides a State Plan, you must comply with the State OSH standards. OSHA 
provides information on State OSH programs: https://www.osha.gov/dcsp/osp/states.html 
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Location for Testing
OVERVIEW
Assuring the appropriate physical environment for performing all phases of testing is important 
for achieving reliable test results. In general, testing should be performed in a clean work area 
with space for patient privacy while safely collecting specimens and performing testing. Each 
testing site should arrange for the proper disposal of hazardous waste.
ENVIRONMENT
Assuring the appropriate physical environment for 
performing testing is important for achieving reliable test 
results. PPM testing sites may include medical or dental 
offices, emergency rooms, ambulatory, hospital laboratories 
or clinics. In general, testing should be performed in a 
clean work area with space for patient privacy while safely 
collecting specimens and performing testing. Each testing 
site should arrange for proper disposal of hazardous waste. 
Workspace—should be stable, level, and allow patient 
confidentiality, disinfection, specimen collection, proper 
testing, and storage of supplies and records.
Lighting—specimen collection and testing area(s) should 
be well lit.
Ergonomics—should be considered and evaluated for the 
tasks performed to avoid eye fatigue and strain to the neck, 
wrists, back, shoulders, and arms. 
Safety labels—equipment and testing areas should be clearly labeled for hazards.
Utilities—such as electricity and water are necessary for microscopes, equipment, and tests.
Housekeeping—testing areas should be clean, organized, and free of clutter. If applicable, 
make sure housekeeping staff are trained on the potential hazards involved in handling 
biological waste and have proper safety training to work with such material.
WASTE DISPOSAL
Hazardous waste cannot be mixed with regular trash. Use proper biohazard containers to 
dispose of waste and sharps contaminated with blood or other potentially infectious materials. 
Each testing site should have site-specific procedures that follow local, state, and federal 
requirements for safe disposal of biohazardous waste generated from specimen collection and 
testing. Local hospitals and/or clinics may be able to provide information about regulated waste 
disposal. Useful websites include:
 ● Federal website: https://www.osha.gov/SLTC/hazardouswaste/index.html
 ● State program site: https://www.osha.gov/dcsp/osp/index.html 
Biohazardous Waste
During the testing process, the biohazard bags and sharps containers used for disposal of 
contaminated materials should be:
 ● as close as possible to the immediate testing area,
 ● upright throughout use,
 ● replaced routinely, and
 ● not overfilled.
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Containers for contaminated waste must be:
 ● constructed to contain all contents and prevent leakage of fluids during handling, storage, 
transport and/or shipping, 
 ● labeled or color-coded to indicate biohazard material, and
 ● closed prior to removal to prevent spillage or protrusion of contents during handling.
Disinfecting Work Surfaces
 ● Disinfect surfaces before performing any test procedure, whenever contamination is 
visible, and before leaving the testing area. Bacteria and viruses can be present in very high 
concentrations in just a few drops of blood or body fluids and some remain infectious for at 
least one week in dried blood on countertops and doorknobs.
 ● Use the appropriate disinfectant for decontaminating your work area. See Appendix G: 
Common Disinfectants and Antiseptics.
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Performing PPM Procedures
OVERVIEW
Preparing for patient testing is important. Equipment used for testing should be maintained, with 
cleaning and servicing performed and documented as directed in the manufacturer’s instructions. 
PROCEDURE MANUAL
Written procedures must be developed, 
approved, and updated for each PPM 
procedure performed at the testing site. 
Textbooks may supplement but not replace 
the laboratory’s written procedures for testing. 
Procedures must be easily available to all 
testing personnel. When writing procedures, 
it is helpful to use a general template with 
standard headings. See Appendix H for 
Procedure Contents and Tips.
Procedure manuals may be created by a testing site in order to provide a single location for all 
documents, forms, and instructions used by the testing site. The procedure manual must be 
approved and dated by the laboratory director prior to patient testing and should be reviewed and 
signed once a year and whenever changes are made. Changes in procedures must be approved, 
signed, and dated by the current laboratory director. Copies of old versions of procedures should 
be removed from the active manual, clearly labeled as inactive, dated, and filed.
Procedure manuals should have instructions and forms for:
99 cleaning and maintenance of the microscope,
99 patient identification and preparation,
99 specimen collection and labelling,
99 specimen acceptability and rejection criteria including detecting inadequately prepared slides,
99 preparation of slides, test reagents, controls, stains, and other test materials,
99 storage of slides, test reagents, controls, stains, and other test materials,
99 performing quality control (QC) procedures,
99 performing the test(s),
99 interpreting and recording the test result(s),
99 reportable range for test results including normal values,
99 entering test results in the patient record and reporting patient results,
99 troubleshooting testing problems,
99 recording temperatures of refrigerators and storage areas,
99 keeping inventories and lot numbers of reagents,
99 handling hazardous waste,
99 cleaning and disinfecting work areas and equipment,
99 selecting and using personal protective equipment,
99 performing work area environmental and ergonomic assessments, and 
99 referring testing to outside laboratories.
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PREPARE FOR TESTING
Testing should be performed in an area with adequate space to safely conduct testing while 
maintaining patient privacy. The microscope should sit on a sturdy flat surface. Testing and 
storage areas should be monitored to be sure they meet specific environmental requirements 
described in the manufacturer’s instructions. The laboratory must have appropriate and sufficient 
equipment, instruments, reagents, materials, and supplies for the type and volume of testing it 
performs. 
Some important points to consider are:
99 Inspect electrical connections to ensure they are functioning properly.
99 Inspect all equipment such as centrifuges to ensure they are functioning properly.
99 Clean work surfaces before and after testing.
99 Inspect and clean the microscope before and after testing.
99 Check inventory regularly to ensure you will have enough reagents, stains, and supplies on 
hand for testing.
99 Verify proper storage of reagents, stains, and supplies.
99 Check and record expiration dates of reagents and stains and discard any reagents or stains 
that have expired.
TESTING EQUIPMENT
All equipment used for testing should be cleaned and maintained according to the laboratory’s 
procedure and policy. Professional servicing should be performed and documented as directed 
by the manufacturer.
Microscope
PPM procedures are limited to those performed 
under a bright-field or phase contrast microscope. 
Bright-field microscopy is a simple technique 
involving specimen illumination by white light and 
contrast in the specimen is created by the absorbance of 
some of the transmitted light. Bright-field microscopy retains the 
natural colors of the specimen which appears darker on a bright 
background. Phase contrast microscopy requires special phase 
contrast objectives and a special phase contrast condenser 
which produce high contrast images of transparent specimens. 
Phase contrast microscopy reveals many cellular elements that 
are not visible with bright-field microscopy.
Microscopes used for testing must be maintained and serviced 
by a professional as directed by the manufacturer. Testing 
sites must document all maintenance and professional service 
activities. See Appendix I for Care and Maintenance of the 
Microscope and Appendix J for Microscope Maintenance Log.
Centrifuge
Maintenance on a centrifuge used for PPM procedures includes:
 ● wiping the chamber, rotor, rotor lid, and centrifuge housing with an approved germicidal 
agent before and after use, and
 ● documenting maintenance performed.
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Components of the Microscope
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QUALITY CONTROL
Quality control (QC) testing gives confidence that your results are accurate and reliable. The 
practitioners are expected to follow the manufacturers’ directions for QC or follow good 
laboratory practices. QC material is often not available to monitor the entire process of 
performing a PPM procedure making QC complicated. Good laboratory practice would dictate 
that controls be run whenever possible and results documented and reviewed for acceptability 
before reporting patient results. The testing site must document all QC testing performed 
including errors and corrective action taken.
Each testing site should have a policy for QC testing establishing the number and type of control 
materials needed and the frequency of testing them. If available, two levels of controls should be 
performed with 
 ● each day of testing,
 ● each new shipment of stains, reagents, or kits,
 ● a change in lot numbers, and
 ● each new operator.
Sites that test under a Certificate for PPM procedures may 
elect to participate in CLIA’s QC option, the Individualized 
Quality Control Plan (IQCP). PPM sites have the 
opportunity to tailor a QC plan customized to their unique 
testing environment. IQCP offers the site flexibility in 
achieving QC compliance, while also providing flexibility 
to adapt to new and future technologies.
IQCP information can be found at http://wwwn.cdc.gov/
clia/Resources/IQCP/.
Developing an IQCP—A Step-By-Step Guide, a workbook 
designed to assist in developing an IQCP for one or more 
test systems, can be found at  
http://wwwn.cdc.gov/clia/Documents/IQCP%20Layout.pdf.
TEST REQUEST
The laboratory or testing site must have a written or electronic request for patient testing from 
an authorized person. Verbal requests may be accepted, but the PPM site must request a written 
or electronic authorization within 30 days of the verbal request and maintain the authorization 
or documentation of its efforts to obtain the authorization. The test request should contain the 
following information:
 ● name and address or other suitable identifiers of the authorized person or laboratory 
requesting the test,
 ● patient’s name and unique patient identifier,
 ● sex and age or date of birth of the patient,
 ● test(s) to be performed,
 ● source of the specimen,
 ● date and time of specimen collection, and
 ● any additional information relevant for a specific test.
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The patient’s chart or medical record may be used as the test request or authorization but must 
be available to the laboratory or testing site at the time of testing and available to CMS or a CMS 
agent upon request. If the test requisition or authorization information is entered into a record 
system or a laboratory information system, the PPM site must ensure the information transcribed 
or entered is transcribed or entered accurately.
Before collecting a specimen, confirm: 
99 The test order—if there is a question whether the order is correct, check with the individual 
who requested the test. 
99 Patient identification—because names can be similar and lead to confusion, use birth dates, 
middle initials, identification numbers or other ways to make sure the specimen is collected 
from the correct patient. 
SPECIMEN COLLECTION
Properly collected patient specimens are critical for accurate and reliable test results. The person 
collecting the specimen should have a good understanding of the type of specimen needed for 
the test and how to collect it. Do not test specimens that are improperly collected or handled. 
PPM procedures use specimens such as body fluids or skin scrapings. The laboratory must 
establish and follow written policies and procedures that ensure positive identification and 
optimum integrity of a patient’s specimen from the time of collection or receipt of the specimen 
through completion of testing and reporting of results. 
Remember, if your site performs waived testing in addition to PPM procedures, only unprocessed 
specimens can be used for waived tests. Use of specimens that require processing such as 
centrifugation, dilution, or extraction is not appropriate for waived tests.
PERFORMING THE TEST
When performing a test, follow the testing steps in 
the exact order as they are in the procedure manual. 
Interpret and record results legibly in a log or 
following the testing site policy and keep results as a 
permanent record. These records should have enough 
detail for easy retrieval of information. Invalid or 
unacceptable results should also be recorded. If a test 
needs to be repeated, record the first result (invalid or 
unacceptable), resolve the problem, and then record 
the repeated result(s). Report the final acceptable 
result only.
Appendix K PPM Procedure Examples provides 
example procedures that may be used by your 
laboratory or testing site. Each example includes 
specimen collection, slide preparation and 
microscopic examination procedures, and images 
of common microscopic findings for the nine PPM 
procedures specified by CLIA. 
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REPORTING TEST RESULTS
Testing sites must have a system in place to ensure the 
timely reporting of test results and other patient-specific 
information. 
The test report must include the following:
 ● patient’s name and unique patient identifier, 
 ● name and address of the testing site,
 ● test report date,
 ● test performed,
 ● specimen source,
 ● test result,
 ● information regarding the condition and disposition 
of specimens that do not meet the laboratory’s 
criteria for acceptability, and
 ● pertinent “normal” values, as determined by the 
laboratory performing the tests.
Guidelines for issuing test reports: 
99 Patient test reports should be legible, standardized, and reported in a timely manner. 
99 Reports from tests conducted on-site should be easily distinguishable from referral laboratory 
test reports. 
99 Patient test reports should only be given to authorized persons. 
99 Verbal test reports should be documented and followed by a written test report. 
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PT Requirements
OVERVIEW
Proficiency testing (PT) for PPM procedures involves the periodic shipment of photographs or 
digital images by a CLIA-approved PT program to a laboratory or testing site for evaluation and 
submission of results back to the PT program. The PT program then compares the testing site 
results with the correct result for that photograph or image, and provides a report back to the 
participating laboratory or testing site. PT is an important tool used to verify the accuracy and 
reliability of testing. 
REQUIREMENTS
PT is not specifically required for PPM procedures. 
However, PPM testing sites need to verify the 
accuracy of their testing at least twice per year. 
Participation in a voluntary PT program will satisfy 
that requirement. If PPM testing sites enroll in a PT 
program, they are subject to all of the requirements 
for PT including those that prohibit PT referral. 
There are many benefits of participating in a PT 
program. PT provides: 
 ● a regular, external check on quality of testing, 
 ● motivation to improve performance, 
 ● comparison of performance with that of other 
participating sites,
 ● an opportunity to obtain feedback and technical 
advice from programs that offer PT, 
 ● assistance in evaluating methods and 
instrumentation, 
 ● assistance with staff education, training and competence monitoring, and 
 ● opportunities for identifying areas needing improvement. 
Many PT programs offer modules for PPM procedures. Although use of a CLIA-approved  
PT program is not a requirement, a list of CLIA- approved PT providers can be found at:  
http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/downloads/ptlist.pdf
See also CMS brochure “Proficiency Testing” available online: http://www.cms.gov/Regulations-
and-Guidance/Legislation/CLIA/Downloads/CLIAbrochure8.pdf 
All CLIA-approved PT programs offer a clinical microscopy module with at least two testing 
events per year.
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Quality System
OVERVIEW
Every testing site that performs PPM testing must establish and maintain written policies and 
procedures for a quality system that covers all phases of the total testing process. The quality 
system needs to include an ongoing quality assessment component that monitors, identifies, 
evaluates, and resolves problems as appropriate for PPM testing. 
COMMUNICATIONS AND COMPLAINT INVESTIGATIONS
The laboratory or testing site must have a system in place to identify and document problems that 
occur as a result of a breakdown in communication between the laboratory and an authorized 
person who orders or receives test results and to ensure documentation of all complaints and 
problems reported to the PPM site. The site must conduct investigations of complaints, when 
appropriate.
QUALITY ASSESSMENT
Assessing testing quality requires planned and 
systematic monitoring and evaluation of the testing 
process. Conducting these activities can lead to reduced 
errors, improved patient outcomes, improved patient 
and employee safety, and reduced costs. Both internal 
and/or external mechanisms for quality assurance 
may be used depending on the needs, resources, and 
practices of the testing site. Examples are listed below. 
Internal assessments are processes for staff 
performing and overseeing testing to evaluate their 
current practices, including:
 ● reviewing the procedure for patient preparation, specimen collection, specimen rejection, 
labeling, preservation and transportation of specimens,
 ● performing QC procedures and documenting results,
 ● reviewing QC records and test results for completeness and accuracy,
 ● documenting and reviewing problems that occur during QC testing and the testing process, 
 ● establishing a corrective action plan to improve processes, 
 ● monitoring to assure correction, 
 ● reviewing policies and procedures for documenting competency of testing personnel, 
 ● documenting and reviewing injury/incident reports, and
 ● reviewing communication and complaint policies.
External assessments are typically performed by an outside party to evaluate current practices 
and offer opportunities for education. Possible options for external review include:
 ● undergoing voluntary inspections by peers or consultants who would evaluate testing 
practices and documentation systems, and offer suggestions for improvement, 
 ● subscribing to PT programs, and 
 ● exchanging samples with other testing sites using the same test method(s) to compare results.
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RECORD KEEPING
Retain records for at least two years or 
as required by your state. The types of 
records to be retained include:
99 Test requisitions and authorizations
99 Patient’s chart or medical record
99 Discontinued test procedures
99 QC records
99 Patient test reports
99 PT records
99 Quality assessment records
Testing sites must maintain specimen 
information that includes the following:
99 The positive identification of the specimen.
99 The date and time of specimen receipt into the laboratory. 
99 The condition and disposition of specimens that do not meet the laboratory’s criteria for 
specimen acceptability. 




The following checklist summarizes the steps to be taken when implementing and overseeing 
PPM testing. 
GENERAL REQUIREMENTS 
99 Understand the procedures that PPM laboratories or testing sites are allowed to perform.
99 Obtain a CLIA Certificate for PPM before offering testing. 
99 Renew the Certificate for PPM every 2 years. 
99 Notify your State Agency of any changes in ownership, name, address, or director within 30 
days, or if you wish to add tests that are not waived or PPM procedures. 
99 Allow announced or unannounced on-site inspections by CMS representatives. 
99 Follow all applicable CLIA requirements for testing:
 • Personnel
 • Facility Administration
 • Proficiency Testing
 • Quality System
 • Inspection
 • Enforcement
99 Follow all applicable state and local requirements. 
99 Follow regulations for confidentiality and patient privacy.
PERSONNEL
99 Follow all applicable CLIA requirements for the laboratory director.
99 Testing must be personally performed by a physician, podiatrist, midlevel practitioner, or 
dentist during a patient visit within the context of a physical examination. 
99Make sure that all testing personnel understand and can perform the test correctly before 
they report patient results. 
99 Periodically assess and document the competency of testing personnel; semiannually during 
the first year and at least annually thereafter.
SAFETY
99 Follow regulations for safety. 
99Wear appropriate personal protective equipment (PPE) such as gloves. 
99 Collect and label a good specimen for testing. 
99 Clean hands and change gloves between patients. 
99 Use the proper biohazard containers to dispose of waste and sharps. 
99Maintain records of occupational injuries and illnesses.
LOCATION FOR TESTING
99 Perform testing in a stable and level area with adequate space for patient privacy while safely 
collecting specimens and performing testing. 
99 Consider environmental issues, such as temperature and humidity, especially in nontraditional 
test settings. 
99 Have clean work surfaces and good lighting for specimen collection and testing. 
99 Dispose of waste safely.
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PERFORMING PPM PROCEDURES
99 Provide a procedure manual that includes specific instructions for each PPM procedure for 
your testing site.
99 Inspect equipment and electrical connections on the microscope to ensure they are 
functional.
99 Check inventory regularly to ensure you will have enough reagents, stains, and supplies on 
hand for testing.
99 Perform and document microscope maintenance.
99 Perform QC as recommended in the laboratory’s PPM procedure manual and policy.
99 Verify the test request.
99 Properly collect and label an appropriate specimen for testing.
99 Do not test specimens that are improperly collected or handled.
99 Perform PPM testing following the steps in the laboratory’s PPM procedure manual.
99Make sure patient reports are legible and reported in a timely manner. 
99 Report patient test results only to authorized persons. 
99 Document verbal reports, followed by a written test report. 
PT REQUIREMENTS
99 Verify accuracy of testing at least twice per year.
99 Use PT as a way to routinely monitor performance.
QUALITY SYSTEM
99 Document communication and complaint issues.
99 Establish written policies and procedures to monitor and evaluate the entire testing process.
99 Perform assessments to improve your current practice.
99 Follow record keeping requirements.
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Resources
CLIA AND HIPAA LINKS
 ● CMS CLIA overview: http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/index.
html?redirect=/CLIA/ 
 ● CLIA regulations: http://wwwn.cdc.gov/clia/Regulatory/default.aspx 
 ● CMS brochure “How to Obtain a CLIA Certificate”: http://www.cms.gov/Regulations-and-
Guidance/Legislation/CLIA/Downloads/HowObtainCLIACertificate.pdf
 ● CMS brochure “What Do I Need to Do to Assess Personnel Competency?”: http://www.cms.gov/
Regulations-and-Guidance/Legislation/CLIA/Downloads/CLIA_CompBrochure_508.pdf 
 ● CLIA requirements for testing under a Certificate for PPM: http://www.gpo.gov/fdsys/pkg/CFR-
2003-title42-vol3/xml/CFR-2003-title42-vol3-part493.xml#seqnum493.19
 ● CLIA Certificate of PPM Procedures Application: http://cms.gov/Medicare/CMS-Forms/CMS-
Forms/Downloads/CMS116.pdf 
 ● CLIA State Agency Contacts: http://cms.gov/Regulations-and-Guidance/Legislation/CLIA/
Downloads/CLIASA.pdf 
 ● FDA’s CLIA Waived Test List: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfclia/
testswaived.cfm 
 ● CDC’s waived tests educational materials: http://wwwn.cdc.gov/clia/Resources/WaivedTests/
 ● HIPAA regulations: http://www.hhs.gov/ocr/privacy/ 
 ● CMS IQCP: http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/Individualized_
Quality_Control_Plan_IQCP.html
 ● CMS Approved PT Programs: http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/
downloads/ptlist.pdf
 ● CMS brochure “Proficiency Testing”: http://www.cms.gov/Regulations-and-Guidance/
Legislation/CLIA/Downloads/CLIAbrochure8.pdf
SAFETY LINKS 
 ● The Centers for Disease Control and Prevention (CDC) and the National Institutes of Health 
(NIH) Biosafety link: http://www.cdc.gov/biosafety/ 
 ● State occupational safety and health programs: https://www.osha.gov/dcsp/osp/index.html 
 ● Medical & Dental Offices—A Guide to Compliance with OSHA Standards at: https://www.osha.
gov/Publications/osha3187.pdf 
 ● Bloodborne Pathogens Standard: https://www.osha.gov/SLTC/bloodbornepathogens/ 
index.html
 ● OSHA’s PPE Fact Sheet: https://www.osha.gov/OshDoc/data_General_Facts/ppe-factsheet.pdf 
 ● CDC Workbook for Designing, Implementing, and Evaluating a Sharps Injury Prevention 
Program: http://www.cdc.gov/sharpssafety/pdf/sharpsworkbook_2008.pdf 
 ● WHO patient safety website: http://www.who.int/patientsafety/en/ 
TRAINING LINKS
 ● CDC Laboratory Training: http://www.cdc.gov/labtraining/
 ● CDC TRAIN: https://cdc.train.org 
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Appendix A
SECURITY AND CONFIDENTIALITY AGREEMENT 
INSTRUCTIONS
Purpose:
The U.S. Department of Health and Human Services (HHS) issued the Privacy Rule to implement 
the requirements of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). 
The Privacy Rule standards address the use and disclosure of individuals’ health information—
protected health information (PHI) by organizations subject to the Privacy Rule (called covered 
entities), as well as standards for individuals’ privacy rights to understand and control how their 
health information is used. 
The Privacy Rule protects all PHI held or transmitted by a covered entity or its business 
associate, in any form or media, whether electronic, paper, or oral. PHI is information including 
demographic data that relates to: 
 ● the individual’s past, present or future physical or mental health or condition, 
 ● the provision of health care to the individual, or 
 ● the past, present, or future payment for the provision of health care to the individual, and 
 ● identification of the individual or for which there is a reasonable basis to believe the 
information can be used to identify the individual. 
PHI includes many common identifiers (e.g., name, address, birth date, Social Security Number). 
Good work practices should be in place to prevent the disclosure of PHI. New employees 
should be trained on these practices. This Security and Confidentiality Agreement form 
documents the agreement of all employees to abide by HIPAA’s Privacy Rule and prevent 
disclosure of patient PHI. 
Contents: 
There are many ways to document compliance training with HIPAA. A blank form is included 
for your use, along with an example form that demonstrates how to correctly enter site specific 
information. 
1. Example Security and Confidentiality Agreement Form Completed. 
2. Blank Security and Confidentiality Form. 
Instructions for Completing the Security and Confidentiality Agreement Form: 
1. Train new employees on the work practices and the importance of HIPAA. 
2. Employees should sign the Security and Confidentiality Agreement Form indicating their 
understanding and willingness to adhere to HIPAA. 
3. File signed form with employee records. 
4. The person who directs or supervises the testing should review and sign when the Security 
and Confidentiality Agreement form is completed. 
Facility: General Health Practice
Location: 123 West Dr. 
 Atlanta, GA 55555
Security and Confidentiality Agreement 
1. I understand that the patient and organization information I will be able to access on-line, by voice-
transmission, and/or on paper is confidential and may be legally privileged. I have an obligation to protect 
data from loss, misuse, or unauthorized access or disclosure. The obligation to maintain confidentiality of 
information extends beyond work time to include personal time as well.
2. I acknowledge that patient information including demographics, patient care and results, are confidential, and 
are protected by legal and regulatory guidelines. Further, this data should not be shared without appropriate 
consents, authorizations or considerations. Accordingly, I understand that I am not allowed to share my 
password/ID access with others and that I have an obligation to close any computer session I open so that my 
access cannot be used by others.
3. I understand that improper access or disclosure of data may subject me to disciplinary and legal action. 
Similarly, if I exceed my computer system access authority or engage in conduct outside of the scope of my 
duties, I may be subject to disciplinary action.




Thomas Smith, MD 








Security and Confidentiality Agreement 
1. I understand that the patient and organization information I will be able to access on-line, by voice-
transmission, and/or on paper is confidential and may be legally privileged. I have an obligation to protect 
data from loss, misuse, or unauthorized access or disclosure. The obligation to maintain confidentiality of 
information extends beyond work time to include personal time as well.
2. I acknowledge that patient information including demographics, patient care and results, are confidential, and 
are protected by legal and regulatory guidelines. Further, this data should not be shared without appropriate 
consents, authorizations or considerations. Accordingly, I understand that I am not allowed to share my 
password/ID access with others and that I have an obligation to close any computer session I open so that my 
access cannot be used by others.
3. I understand that improper access or disclosure of data may subject me to disciplinary and legal action. 
Similarly, if I exceed my computer system access authority or engage in conduct outside of the scope of my 
duties, I may be subject to disciplinary action.










All employees need to understand their role in the organization as a whole, learn the 
expectations of their supervisor, and practice the basic elements of their job. Their experience 
in the first few weeks will have a significant effect on the level of commitment and ability to 
become productive quickly. 
Checklists provide a structured approach to training new employees. Checklists allow new 
employees to work through the training agenda at their own pace, spending less time on 
issues with which they are already familiar, and more time on those issues that are new or 
unfamiliar to them. 
A well-designed training checklist can serve as a guide for new arrivals as they learn all the 
elements of their job.
Contents: 
There are many ways to document training. A blank checklist is included for your use, along 
with an example checklist that demonstrates how to correctly enter site specific information. 
1. Example Training Checklist Completed. 
2. Blank Training Checklist. 
Instructions for Completing the Training Checklist Form: 
1. The employee should read the procedure that they will be trained to perform.
2. The trainer should review the procedure before beginning the training.
3. The trainer will demonstrate the procedure explaining each step as they perform it.
4. The trainee will perform the procedure and be able to explain key steps.
5. Upon completion, the trainer and trainee will document the training with the checklist 
and address any issues or concerns that arise. If re-training is necessary, this should be 
documented on the checklist.
6. The checklist should be filed with the employee’s other records.
EXAMPLE
Facility: General Health Practice
Location: 123 West Dr. 
 Atlanta, GA 5555
Training Checklist
Trainee: Michelle Richards
Date: 06/03/2016 Trainer: Thomas Smith
Test: ABC Test Kit
Trainer should review all material listed below and verify that the trainee has read the appropriate procedures or manufacturer 






1. Trainee locates, reads and understands policies and procedures for the PPM test(s). 06/03/2016 MR TS
2. Trainer discusses principle of test procedure so that trainee understands scope and purpose 
of the test.
06/03/2016 MR TS
3. Trainer identifies equipment, reagents, stains, and supplies to perform test and trainee 
knows location.
06/03/2016 MR TS
4. Trainer demonstrates compliance with standard safety precautions including appropriate 
PPE and trainee understands the precautions.
06/03/2016 MR TS
5. Trainee observes proper specimen collection, handling, and storage requirements for 
patient specimens.
06/03/2016 MR TS
6. Trainee is able to reconstitute, prepare, and store reagents required for the PPM test. 06/03/2016 MR TS
7. Trainee demonstrates knowledge of microscope components and proper microscope 
maintenance.
06/03/2016 MR TS
8. Trainee observes test procedure performed by trainer. 06/03/2016 MR TS
9. Trainee performs the procedure and should be able to:
a. Identify proper specimen type, use of the appropriate collection device, labeling, 
handling, and storage of specimens
b. Organize work area for testing including preparation of reagents
c. Perform quality control (QC) samples, if available prior to performing patient samples
d. Set up timer and follow incubation times per the PPM procedure
e. Interpret results
f. Decontaminate and clean work area, including proper disposal of hazardous waste and 
sharps and microscope cleaning.
g. Document corrective action taken for errors in testing and unacceptable QC.
06/06/2016 MR TS
10. Data entry, recording, and reporting test results. Trainee demonstrates the ability to perform: 
a. Test order and accessioning




Trainee Comments: Dr. Smith was clear in his explanations and knew the answers to my questions
Trainee Signature: Michelle Richards Date: 06/06/2016
Trainer Comments: Michelle was attentive and followed directions during the instruction







Trainer should review all material listed below and verify that the trainee has read the appropriate procedures or manufacturer 






1. Trainee locates, reads and understands policies and procedures for the PPM test(s).
2. Trainer discusses principle of test procedure so that trainee understands scope and purpose 
of the test.
3. Trainer identifies equipment, reagents, stains, and supplies to perform test and trainee 
knows location.
4. Trainer demonstrates compliance with standard safety precautions including appropriate 
PPE and trainee understands the precautions.
5. Trainee observes proper specimen collection, handling, and storage requirements for 
patient specimens.
6. Trainee is able to reconstitute, prepare, and store reagents required for the PPM test.
7. Trainee demonstrates knowledge of microscope components and proper microscope 
maintenance.
8. Trainee observes test procedure performed by trainer.
9. Trainee performs the procedure and should be able to:
a. Identify proper specimen type, use of the appropriate collection device, labeling, 
handling, and storage of specimens
b. Organize work area for testing including preparation of reagents
c. Perform quality control (QC) samples, if available prior to performing patient samples
d. Set up timer and follow incubation times per the PPM procedure
e. Interpret results
f. Decontaminate and clean work area, including proper disposal of hazardous waste and 
sharps and microscope cleaning.
g. Document corrective action taken for errors in testing and unacceptable QC.
10. Data entry, recording, and reporting test results. Trainee demonstrates the ability to perform: 
a. Test order and accessioning











The individual overseeing testing acts as an advocate for employees by gathering and distributing 
the resources needed by employees in order for them to be able to do a good job and by 
providing positive encouragement for a job well done. They should display the interpersonal skills 
required to engage employees and enhance their self-confidence. 
Feedback from employees on the training experience provides valuable information to employers 
seeking to improve or identify gaps in their training programs. This method also opens an avenue 
of communication between the employee and employer. 
Many training programs fail to deliver the expected organizational benefits. Having a well-
structured measuring system in place can help you determine where the problem lies.
Contents: 
There are many ways to evaluate training. A blank evaluation form is included for your use, 
along with an example evaluation form that demonstrates how to correctly enter site specific 
information.
1. Example Training Evaluation Completed. 
2. Blank Training Evaluation. 
Instructions for Completing the Training Evaluation Form: 
1. After training is completed, the trainee should complete the Training Evaluation. 
2. The trainee should be honest and open about the training experience without fear of 
remedial action or other adverse reactions as a result of the evaluation. 
3. Management should review and compile the results to assess the training program’s 
effectiveness and make improvements and changes to the program as necessary.
EXAMPLE
Facility: General Health Practice
Location: 123 West Dr. 
 Atlanta, GA 5555
Training Evaluation
Date: 06/06/2016 Trainee: Michelle Richards
Item
Circle







Was the process clearly 
explained?
Y N 3
Was (were) the procedure(s) 
clearly demonstrated?
Y N 3
Were you shown where to 
get supplies and equipment?
Y N 3
Were you given enough time 
to practice?
Y N I felt rushed and I could have used more time to read the fields. 1
Was the trainer 
approachable?
Y N 3
Did you feel comfortable 
asking questions?
Y N 3
If the trainer did not know 
the answer, could he/she 
find the information?
Y N 3
When you did the 
procedure(s), were you 
corrected respectfully?
Y N 3
Did you get constructive, 
timely feedback?
Y N 3
Did you feel comfortable 
performing the procedure(s) 
on your own?
Y N
I felt like I needed a few more times identifying the organisms 
prior to testing patient specimens.
1
Were you asked questions 
to gauge your knowledge 
and understanding of the 
process or procedure(s)?
Y N 3














Was the process clearly 
explained?
Y N
Was (were) the procedure(s) 
clearly demonstrated?
Y N
Were you shown where to 
get supplies and equipment?
Y N
Were you given enough time 
to practice?
Y N
Was the trainer 
approachable?
Y N
Did you feel comfortable 
asking questions?
Y N
If the trainer did not know 
the answer, could he/she 
find the information?
Y N
When you did the 
procedure(s), were you 
corrected respectfully?
Y N
Did you get constructive, 
timely feedback?
Y N
Did you feel comfortable 
performing the procedure(s) 
on your own?
Y N
Were you asked questions 
to gauge your knowledge 








The ability of each person to perform their duties should be assessed following training and 
periodically thereafter. Retraining and reassessment of employee performance needs to be done 
when problems are identified with employee performance. The training and assessment program 
should be documented and specific for each job description. Activities requiring judgment or 
interpretive skills need to be included in the assessment.
Competency assessment can
 ● identify key training areas,
 ● identify processes that need improvement,
 ● provide supervisors and managers with data on employee performance, and
 ● provide evidence to customers and management that the laboratory assures quality with 
trained staff.
Contents: 
There are many ways to assess competency. A blank assessment is included for your use, along 
with an example assessment that demonstrates how to correctly enter site-specific information. 
1. Example Competency Assessment Completed. 
2. Blank Competency Assessment. 
Instructions for Completing the Competency Assessment Form: 
1. Record the facility name and location. 
2. Record the employee’s name and the procedure being observed. 
3. Have the employee perform the procedure. 
4. Record whether the steps completed were satisfactory or unsatisfactory, note any comments, 
and document any corrective action needed. 
5. Sign and date the form. 
6. Have the employee sign and date the form and provide comments. 
EXAMPLE
Facility: General Health Practice
Location: 123 West Dr. 
 Atlanta, GA 55555
Competency Assessment
Employee Name: Michelle Richards
Procedure to be Observed: PPM Procedure: KOH Preparation
Instructions to the Employee:
1. Review the procedure.
2. Perform the procedure, including collecting the specimen, equipment maintenance, and records management, 
while being observed.
3. Your performance will be based on how well you follow the procedure. You may refer to the written procedure 
during the performance of the procedure. If the evaluation of your performance is unsatisfactory, you will be 
given instructions for corrective action.
4. If you find that the written procedure is unclear or missing necessary information, please make a note in the 
employee comments section below.
Instructions to the Observer:
1. Select previously analyzed specimens or samples with known results for the employee to demonstrate the 
procedure. 
2. Directly observe the employee perform each step of the procedure. If any step of the procedure is performed 
incorrectly, please note this in the observer comments section.
3. Test the employee’s problem solving skills with a question or observe the employee resolving a problem. 
4. If procedure is followed correctly, mark as satisfactory. If there are steps that are not followed, then mark 
unsatisfactory and describe the corrective action necessary to obtain a satisfactory rating. 
5. Record your name and date on the ‘observed by’ line.
6. Ask the employee to sign and date the form and file appropriately.
Assessment of Specimen Handling  _________ Satisfactory  __________ Unsatisfactory
Assessment of Test Performance  _________ Satisfactory  __________ Unsatisfactory
Assessment of Quality Control  _________ Satisfactory  __________ Unsatisfactory
Assessment of Data Management  _________ Satisfactory  __________ Unsatisfactory
Assessment of Problem Solving  _________ Satisfactory  __________ Unsatisfactory
Observer Comments: 
Observer Comments: 
Michelle did not know where to file completed result forms
I now understand the proper filing procedures
Reviewed by Employee: Michelle Richards Date: 06/27/2016
Observed By: Thomas Smith, MD Date: 06/27/2016





Procedure to be Observed:
Instructions to the Employee:
1. Review the procedure.
2. Perform the procedure, including collecting the specimen, equipment maintenance, and records management, 
while being observed.
3. Your performance will be based on how well you follow the procedure. You may refer to the written procedure 
during the performance of the procedure. If the evaluation of your performance is unsatisfactory, you will be 
given instructions for corrective action.
4. If you find that the written procedure is unclear or missing necessary information, please make a note in the 
employee comments section below.
Instructions to the Observer:
1. Select previously analyzed specimens or samples with known results for the employee to demonstrate the 
procedure. 
2. Directly observe the employee perform each step of the procedure. If any step of the procedure is performed 
incorrectly, please note this in the observer comments section.
3. Test the employee’s problem solving skills with a question or observe the employee resolving a problem. 
4. If procedure is followed correctly, mark as satisfactory. If there are steps that are not followed, then mark 
unsatisfactory and describe the corrective action necessary to obtain a satisfactory rating. 
5. Record your name and date on the ‘observed by’ line.
6. Ask the employee to sign and date the form and file appropriately.
Assessment of Specimen Handling  _________ Satisfactory  __________ Unsatisfactory
Assessment of Test Performance  _________ Satisfactory  __________ Unsatisfactory
Assessment of Quality Control  _________ Satisfactory  __________ Unsatisfactory
Assessment of Data Management  _________ Satisfactory  __________ Unsatisfactory
Assessment of Problem Solving  _________ Satisfactory  __________ Unsatisfactory
Observer Comments: 
Observer Comments: 
Reviewed by Employee: Date:
Observed By: Date:
Corrective Action Needed (if applicable): 
38 — Appendices
Appendix E
EYEWASH STATION WEEKLY MAINTENANCE LOG 
INSTRUCTIONS
Purpose:
An eyewash station is an important safety device in a laboratory. Eyewash stations provide 
immediate decontamination of the eyes after exposure to hazardous substances. There are two 
types of eyewash stations: plumbed and gravity-fed. Plumbed eyewash stations are permanently 
connected to a source of potable water and should be checked and flushed weekly to ensure 
proper functioning. This check should include a review of the following to ensure:
 ● Eyewash station is free from obstruction
 ● Eyewash station is easily activated
 ● Nozzles are equipped with protective covers
 ● Covers are removed upon activation of the eyewash station
 ● Water flows from both eyepieces
 ● Flow of water is clear after flushing
 ● Flow of water is steady
Contents:
There are many ways to document eyewash station maintenance. A blank log is included for your 
use, along with an example log that demonstrates how to correctly enter site specific information.
1. Example Eyewash Station Weekly Maintenance Log Completed. 
2. Blank Eyewash Station Weekly Maintenance Log. 
Instructions for Completing the Eyewash Station Weekly Maintenance Log Form: 
1. Post an eyewash station weekly maintenance log near the eyewash station.
2. Perform a check of the eyewash station weekly.
3. Record the date of the eyewash station maintenance.
4. Record the initials of the person who performed the maintenance of the eyewash station.
5. Document action when the eyewash station requires any repairs or maintenance by a service 
professional.
6. The laboratory director should review and sign the eyewash station weekly maintenance log.
EXAMPLE
Facility: General Health Practice
Location: 123 West Dr. 
 Atlanta, GA 5555
EYEWASH STATION WEEKLY MAINTENANCE LOG
Eyewash Station Location: Year: 2016PPM/Microscope Room























































Problems encountered and corrective action taken:
*On 09/12/2016 the caps were off of eye pieces. I replaced the caps
Reviewed by: Thomas Smith, MD Date: 12/30/2016
Facility: 
Location:  
EYEWASH STATION WEEKLY MAINTENANCE LOG
Eyewash Station Location: Year:




























































The safety plan describes policies and procedures to ensure the safety of the personnel who 
perform testing. Participation and cooperation in following safety precautions may also prevent 
endangerment of the health and safety of fellow workers and the surrounding community. 
II. PLAN AVAILABILITY 
The plan that includes policies and procedures to assure safety needs to be available to all 
employees for review. All employees are expected to familiarize themselves with these safety 
responsibilities. A site-specific copy of the safety plan needs to be located in each testing area. 
Some useful safety documents can be found here: http://www.cdc.gov/od/ohs/biosfty/biosfty.htm 
III. RESPONSIBILITIES
Implementation of the safety plan is a shared responsibility. The individual overseeing testing and 
personnel who perform the testing all have roles to play. These roles are outlined below. 
A. Individual Overseeing Testing 
1. Establish a plan that includes policies and procedures for employee safety. 
2. Designate an area in each testing area for storage and easy access of the site-specific  
safety plan. 
3. Make sure testing personnel and other staff follow the guidelines in the safety plan. 
4. Provide site-specific safety training to all new employees BEFORE they perform testing. 
5. Document completion of safety training for all employees, including housekeeping staff, 
and maintain training records. 
6. Provide appropriate personal protective equipment (PPE) and engineering controls 
needed to work safely. Make sure that such equipment is used correctly and is in  
working order. 
7. Identify and offer to employees appropriate immunizations for the testing being 
performed. 
8. Correct all unsafe practices immediately. 
9. Review and update policies and procedures for employee safety annually. 
B. Testing Personnel 
1. Review the site-specific safety plan. 
2. Attend laboratory safety training. 
3. Make sure training is properly documented. 
4. Complete the Appendix F1. Safety Training Checklist. 
5. Follow all safety policies and procedures.
6. Use appropriate engineering controls and PPE. 
7. Report all incidents, accidents, and potential exposures to the individual overseeing testing. 
EXAMPLE
IV. GENERAL SAFETY GUIDELINES 
To ensure a safe work environment, follow the guidelines below. 
A. Conduct 
1. Maintain professionalism at all times. 
2. Avoid working alone, if possible. 
3. No horseplay in the workplace. 
4. Learn the proper location, operation, and maintenance of safety equipment (i.e. fire 
alarms, fire extinguishers, eyewash stations, and safety showers). 
B. Avoidance of Routine Exposures 
1. Make certain that you are familiar with emergency and evacuation procedures. 
2. Read all warning labels and manufacturer instructions prior to operating ANY equipment. 
*Do not use damaged equipment. 
3. Be aware of potential hazards in the testing area. 
4. Wear appropriate PPE. 
5. Report ALL exposures immediately to the individual overseeing testing. 
C. Personal Hygiene 
1. Smoking, drinking, eating, gum chewing, applying or removing contact lenses and the 
application of cosmetics are forbidden in the testing area. 
2. Do not store food in freezers or refrigerators designated for testing. 
3. Wash hands frequently and thoroughly. At a minimum, before and after each patient. 
4. Wear footwear that completely covers the feet. 
5. Tie or pin-up long hair while performing the testing procedures. 
6. Be cautious of any unsafe laboratory conditions. Notify the individual overseeing testing 
of any hazards. 
D. Housekeeping Practices 
1. Keep testing areas clean, organized, and free of clutter. 
2. Clean spills efficiently and properly from work area and floors. Notify the individual 
overseeing testing. 
3. Do not impede or use doorways and walkways for storage. 
4. Keep all exits, emergency equipment and controls accessible. 
5. Flush eyewash stations, if available, weekly and emergency showers every six months. 
Keep records for documentation. 
E. Ergonomics 
1. Perform an ergonomic assessment of work area, including chair, workstation, desk,  
and computer. 
2. Provide an environment that limits ergonomic stress. 
V. SAFETY SIGNAGE AND LABELING 
The individual overseeing testing is responsible for posting safety and hazard warning signs, as 
necessary, for use by all employees. The following information should be posted in and next to 
testing areas: 
A. Phone numbers of emergency personnel/facilities, and the individual overseeing testing. 
B. Identity labels, showing contents of containers and associated hazards.
C. Location signs for safety showers, eyewash stations, other safety and first aid equipment 
and exits. 
D. Warnings at areas or equipment where special or unusual hazards exist. 
VI. SHARPS REDUCTION POLICY PRACTICES 
The Occupational Safety and Health Administration (OSHA) Bloodborne Pathogen Standard 
requires laboratories to institute practices that reduce injuries from needles and other sharp 
objects used in the testing site. The following practices need to be used by all personnel who 
collect samples and perform testing: 
A. Do not touch broken glass; it should be removed mechanically using forceps, brush and 
dust pan, etc. Deposit in sharps container. 
B. Needles (do not resheath, recapping of needles is prohibited), syringes, slides, pipettes, 
capillary tubes, scalpels, broken glass must be placed in a rigid puncture-resistant 
disposable container with a lid. 
C. Needleless systems should be used whenever possible. Sharp objects such as needles, glass 
pipettes, etc. should be used only when there is no alternative available.
VII. CONTAMINATION Control and Decontamination PROCEDURES 
The procedures listed below are intended as a resource for preparing and responding to spills 
and testing personnel exposure. 
A. Spill Kit 
1. Testing sites should keep a spill kit handy if working with a hazardous or infectious 
substance. 
2. Biohazard Spill Kit Contents: 
a) Disinfecting solution 
b) Forceps or tongs, disposable broom and dustpan or other device for handling sharps 
c) Paper towels 
d) Biohazard bags 
e) Waterproof utility gloves and examination gloves
f) Face protection (face shield, splash goggles, disposable face mask) 
g) Disposable scrubs 
h) Spill sign to post on door to room 
B. Biohazard Spill Procedure 
1. Avoid inhaling airborne material while quickly leaving the room. 
2. Notify others to leave. Close door and post with a warning sign. 
3. Remove contaminated clothing, turn exposed area inward and place in a biohazard bag. 
Launder contaminated clothing/lab coats in hot water with bleach. 
4. Wash exposed skin with antiseptic soap and water. 
5. Wear appropriate PPE: gloves, lab coat, and splash goggles and face mask.
6. Cover spill with paper towels and carefully pour a 10% sodium hypochlorite (bleach) 
solution or other appropriate disinfectant on the towels and around the spill allowing 
it to mix with the material. If using a disinfectant product, follow the manufacturer’s 
instructions for proper use, concentration, and contact time. When using bleach for this 
initial decontamination step, allow it to soak for at least 20 minutes. 
7. Using forceps or tongs pick up any pieces of broken glass and place them in a sharps 
container. 
8. Carefully pick up the absorbent toweling and the bulk of the spill material and discard 
these into a biohazard bag. Use fresh toweling to wipe up any residual material and 
discard along with the other disposable materials. 
9. Clean the surface with an EPA-registered detergent/disinfectant and allow to air dry. 
Alternatively, clean the surface with detergent and water, followed with an application of 
bleach solution. Allow to air dry. 
10. Remove disposable gloves and discard as biohazardous waste. Discard any disposable 
protective clothing used during spill clean-up. Clean and disinfect utility gloves, face 
shield, goggles, and any other reusable item used during spill clean-up. 
11. Wash hands with antiseptic soap and water. 
12. Dispose of biohazardous waste following applicable regulations. 
13. Notify individual overseeing testing and document the incident accordingly. 
14. Replenish or replace any items used in the spill kit. 
C. Exposed Personnel Procedures
1. Splashes to face (eyes, nose and mouth) 
a) Use the eyewash station to flush exposed area. 
b) Report to the individual overseeing testing immediately for prophylaxis, if necessary.
2. Hands or other exposed skin 
a) Wash with antiseptic or soap. 
b) Report to the individual overseeing testing immediately for prophylaxis, if necessary. 
3. Needlesticks and Puncture Wounds 
a) Squeeze around the injury to encourage the flow of blood out of the wound. 
b) Report to the individual overseeing testing immediately for prophylaxis, if necessary. 
D. Documentation Procedures 
1. All spills and/or exposures should be documented. 
2. The incidents should be reviewed by the individual overseeing testing and work practices 
put in place to prevent reoccurrence, if necessary. Appendix F2: Example Incident Report. 
3. Comply with OSHA injury and illness reporting. 
VIII. APPENDICES




SAFETY TRAINING CHECKLIST INSTRUCTIONS
Purpose:
Workers in many different occupations are at risk of exposure to bloodborne pathogens, including 
hepatitis B, hepatitis C, and HIV. First aid team members, housekeeping personnel, nurses, and 
other healthcare providers are examples of workers who may be at risk of exposure.
Contents:
There are many ways to document safety training for new employees. A blank checklist is 
included for your use, along with an example checklist that demonstrates how to correctly enter 
site specific information.
1. Example Safety Training Checklist Completed.
2. Blank Safety Training Checklist. 
Instructions for Completing the Safety Training Checklist: 
1. Train new employees on work practices, procedures, and the importance of safety. 
2. Employees should sign the Safety Training Checklist indicating their understanding and 
willingness to follow established safety practices. 
3. File signed form with employee records.
EXAMPLE
Facility: General Health Practice
Location: 123 West Dr. 
 Atlanta, GA 5555
Safety Training Checklist
Purpose: To ensure new employees have been properly advised and trained regarding safety-related issues. Checklist MUST be 






Discussed use of universal precautions when working with 
human blood or body fluids including Bloodborne Pathogen 
training.
06/01/2016 MR TS
Received appropriate immunizations as determined by individual 
overseeing testing. 
06/01/2016 MR TS
Discussed hazardous chemical inventory and safe use of 
hazardous chemicals in the laboratory. Reviewed Material Safety 
Data Sheets (MSDS).
06/01/2016 MR TS
Shown where First AID Kits and AED’s (if available) are located. 06/01/2016 MR TS
Shown where Biosafety and Chemical Spill Kits (if applicable) 
are located.
06/01/2016 MR TS
Reviewed procedures for obtaining supplies. 06/01/2016 MR TS
Discussed required use of personal protective equipment (PPE). 06/01/2016 MR TS
Provided appropriate PPE. 06/01/2016 MR TS
Shown where fire extinguishers are located. 06/01/2016 MR TS
Discussed ergonomics in the work place. 06/01/2016 MR TS
Reviewed procedure on waste disposal:
 • Infectious
 • Non-infectious
 • Hazardous chemical
 • Sharps
06/01/2016 MR TS
Reviewed emergency response procedures:
 • Infectious material spill or release
 • Hazardous chemical spill or release
 • Fire or explosion
 • Medical emergency
 • Bomb threat
 • Shelter in place
06/01/2016 MR TS
Provided instructions on Incident Reporting. 06/01/2016 MR TS
Trainee Comments: Michelle has worked in a CLIA certified laboratory previously and is familiar with the 
appropriate safety requirements. I feel confident that she understands and will comply with our safety rules.
Michelle Richards Date: 06/01/2016Employee Signature:
Joe Smith, MD Date: 06/01/2016Lab Director Signature:




Purpose: To ensure new employees have been properly advised and trained regarding safety-related issues. Checklist MUST be 






Discussed use of universal precautions when working with 
human blood or body fluids including Bloodborne Pathogen 
training.
Received appropriate immunizations as determined by individual 
overseeing testing. 
Discussed hazardous chemical inventory and safe use of 
hazardous chemicals in the laboratory. Reviewed Material Safety 
Data Sheets (MSDS).
Shown where First AID Kits and AED’s (if available) are located.
Shown where Biosafety and Chemical Spill Kits (if applicable) 
are located.
Reviewed procedures for obtaining supplies.
Discussed required use of personal protective equipment (PPE).
Provided appropriate PPE.
Shown where fire extinguishers are located.
Discussed ergonomics in the work place.
Reviewed procedure on waste disposal:
 • Infectious
 • Non-infectious
 • Hazardous chemical
 • Sharps
Reviewed emergency response procedures:
 • Infectious material spill or release
 • Hazardous chemical spill or release
 • Fire or explosion
 • Medical emergency
 • Bomb threat
 • Shelter in place









Some injuries, exposures, or other incidents require immediate first aid and post-exposure 
intervention to limit risks to life and health. Workers should be familiar with all aspects of the work 
being done in their work areas and the appropriate steps to take if a workplace safety or medical 
incident occurs. 
Patient testing has the potential to expose individuals to a large variety of biological and 
chemical agents while performing job duties. Extreme care should be taken to limit this risk. If 
such an event should occur, follow the site-specific guidelines in your work area for immediate 
intervention. Be familiar with the recommendations for immediate response if an exposure 
occurs. Ask the individual overseeing testing for site-specific information regarding your own 
work area. 
All work-related injuries, illnesses, and incidents (chemical spill, minor fire, injury, etc.) should be 
evaluated from a standpoint of future prevention. Occupationally-related injuries and illnesses 
may offer opportunities for work practice or safety improvements in the workplace.
Contents:
There are many ways to document incidents. A blank report is included for your use, along with 
an example report that demonstrates how to correctly enter site specific information. .
1. Example Incident Report Checklist Completed.
2. Blank Incident Report Checklist.
Instructions for Completing the Incident Report Checklist: 
1. The employee involved in the incident should complete the Incident Report to the best of 
their abilities.
2. Once completed, the incident should be evaluated for corrective action.
3. Corrective action should be taken and documented on the Incident Report.
4. The individual overseeing testing should review and sign the report.
5. File the report accordingly.
6. If the site has ten or more employees at any time during the last calendar year, you must keep 
OSHA Injury & Illness Recordkeeping Forms, 300 series available at: https://www.osha.gov/
recordkeeping/RKforms.html 
7. If your company has ten or fewer employees at all times during the last calendar year, you do 
not need to keep OSHA injury and illness records unless OSHA informs you in writing that you 
must keep records.
8. Report to OSHA any workplace incident resulting in the death of any employee from a 
work-related incident or the in-patient hospitalization of three or more employees as a result 
of a work-related incident. Reporting of the fatality/multiple hospitalization may be done by 
telephone or in person to the OSHA office nearest to the site of the incident.
EXAMPLE
Facility: General Health Practice
Location: 123 West Dr. 
 Atlanta, GA 55555
Incident Report
Name of Person Involved in Incident: Michelle Richards
Location of Incident: PPM Laboratory/Microscope 
Reviewed by: Thomas Smith, MD Date: 06/30/2016
Date of Incident: Time of Incident: 2:30 PM06/30/2016
A. First Aid: Wash, Burn, Band-Aid, Eyewash, or other:
B. Medical Treatment beyond First Aid: 
C. Clean-up or Spill D. Fire E. Evacuation 
Action Taken:
To be completed by person involved in incident: 
Did your supervisor advise you on the hazards of the workplace as part of training? Y / N
Were you wearing appropriate PPE (gloves, face shield, etc) properly? Y / N
Did you read and sign the Safety Training Checklist before working in the lab? Y / N
What do you believe was the cause of the incident?
Need to use a broom and dustpan to pick up broken glass
Description of Incident: [Type of incident, e.g., illness, accident, injury. Indicate circumstances and who was involved. Indicate any 
substances (e.g., amount and kind of chemical) or object involved.]
Dropped a glass slide that broke and cut finger when picking it up





Name of Person Involved in Incident:
Location of Incident:
Reviewed by: Date:
Date of Incident: Time of Incident:
A. First Aid: Wash, Burn, Band-Aid, Eyewash, or other:
B. Medical Treatment beyond First Aid: 
C. Clean-up or Spill D. Fire E. Evacuation 
Action Taken:
To be completed by person involved in incident: 
Did your supervisor advise you on the hazards of the workplace as part of training? Y / N
Were you wearing appropriate PPE (gloves, face shield, etc) properly? Y / N
Did you read and sign the Safety Training Checklist before working in the lab? Y / N
What do you believe was the cause of the incident?
Description of Incident: [Type of incident, e.g., illness, accident, injury. Indicate circumstances and who was involved. Indicate any 
substances (e.g., amount and kind of chemical) or object involved.]
Preventive Measures to Prevent Reoccurrence (if applicable):
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Appendix G
COMMON DISINFECTANTS AND ANTISEPTICS
Note: Any mention of trade names is for identification purposes only and is not intended as an 
endorsement. Proprietary disinfectant products should be used in accordance with the manufacturer’s 
instructions for concentration, contact time, or other conditions of use.
Selected EPA-registered disinfectants: A list of EPA’s registered sterilizers, tuberculocides, and 
antimicrobial products against certain bacteria and viruses can be found at: http://www.epa.gov/
oppad001/list_a_sterilizer.pdf 
1. Chlorine compounds are powerful disinfectants that are inexpensive and easy to obtain. 
Sodium hypochlorite or household chlorine bleach solutions possess intermediate-level 
disinfectant properties. For maximum potency, the working solution should be prepared 
fresh at the time of use or daily as needed, but studies show that weekly preparations work 
too. A 10% bleach solution is also referred to as 1/10, 1:10 or 5,000 ppm bleach solution. The 
directions for preparation are: 
Note: Bleach will corrode some equipment. Refer to manufacturer’s recommendations for cleaning and 
disinfecting procedures. 
2. Alcohols are considered intermediate level disinfectants. Alcohol solutions are often used as 
a skin antiseptic. Alcohols, such as isopropyl (rubbing) alcohol, are well suited to rapidly kill 
bacteria on the skin surface.
3. Commercial Products. The EPA provides a list of registered commercial products that are 
effective against certain bacteria and viruses. Examples are ‘Lysol’ (or a cresol and soap 






















PROCEDURE CONTENTS AND TIPS
Procedure Contents:
Testing sites must develop procedures for each PPM test performed. The procedures must 
be approved and signed by the Laboratory Director prior to use in patient testing. They 
must be available and followed by testing personnel. Procedures can be developed from the 
manufacturer’s instructions or textbooks, to also include specific instructions for your testing 
site. When writing procedures, it is helpful to use a general template with standard headings. 
Headings that are often used for writing procedures are: 
 ● Title (Test Name)—the title should clearly state the intent of the procedure. 
 ● Purpose—states what the test measures and clinical use of the result. 
 ● Materials—lists all materials, reagents, stains, supplies, equipment needed and how to 
prepare and store them. 
 ● Specimen—describes the type of specimen, how to collect, label and store it, and 
patient pre-test information or preparation instructions. Information on identification 
and handling of unacceptable specimens or inadequately prepared slides should also be 
included in this section.
 ● Special Safety Precautions—indicates any safety requirements that are unique to this 
procedure or need to be highlighted. 
 ● Quality Control (QC)—describes the types of controls for the test, steps to perform QC, 
how often to test, interpreting the results, and how to recognize and correct problems. 
 ● Procedure—use the manufacturer or textbook instructions, supplemented with site-
specific information that includes: 
 • Step by step test instructions for each PPM procedure 
 • Preparation of slides, solutions, or other materials used in testing 
 • Pertinent literature references
 ● Method Performance Specifications—this section should include information about 
precision, accuracy, and specificity as well as the reportable and expected results for the 
PPM test. Information on interfering substances, or conditions that can affect the test 
result should also be included in this section. 
 ● Interpreting, Recording, and Reporting Results 
 • How to read and interpret test results (photos or diagrams are especially useful) 
 • Comparison of the results to the expected values or diagnostic findings to determine  
if the result is normal, abnormal, or indeterminate 
 • Follow-up for indeterminate results 
 • Criteria for referral of specimens including procedures for specimen submission and 
handling, if needed
 • How to report results 
 • Actions to take if results cannot be reported (invalid or out of range values). Include 




Care and Maintenance of the Microscope
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Appendix J
MICROSCOPE MAINTENANCE LOG INSTRUCTIONS
Procedure Contents:
Microscopes used for testing must be maintained and serviced by a professional as directed 
by the manufacturer. Testing sites must document all maintenance and professional service 
activities. Maintenance may include: 
 ● clean dust in microscope area
 ● clean oculars
 ● clean stage
 ● clean condenser
Procedure Contents:
There are many ways to document microscope maintenance. A blank log is included for 
your use, along with an example log that demonstrates how to correctly enter site specific 
information.
1. Example Microscope Maintenance Log Completed. 
2. Blank Microscope Maintenance Log. 
Instructions for Completing the Microscope Maintenance Log: 
1. Post a microscope maintenance log near the microscope.
2. Perform microscope maintenance weekly.
3. Record the date of the microscope maintenance.
4. Record the initials of the person who performed the maintenance.
5. Document action taken when the microscope requires any repairs or maintenance by a 
service professional.
6. The laboratory director should review and sign the microscope maintenance log.
EXAMPLE
Facility: General Health Practice
Location: 123 West Dr. 
 Atlanta, GA 5555
MICROSCOPE MAINTENANCE LOG
Microscope Location: Year: 2016PPM/Microscope Room























































Problems encountered and corrective action taken:


































































These procedures are provided as a guide and should not take precedent over established 
laboratory or testing site procedures. Procedures were developed using the cited references 
below.
Contents:
There are nine PPM procedures specified by CLIA. This appendix includes specimen collection, 
slide preparation and microscopic examination procedures, and images of common microscopic 
findings for each of the PPM procedures. The high power (40X) objective was used for 
identification of the majority of images provided.
In addition to the procedures used in your laboratory or testing site, it is recommended that 
reference texts, atlases, and posters are available for reference when performing PPM testing.
References:
The following references were used in development of the PPM procedures test instructions. 
 ● Bauer JD, Clinical Laboratory Methods. 9th ed. St. Louis, MO; CV Mosby Co; 1982.
 ● Versalovic J, Carroll KC, Jorgensen JH, Funke G, Landry ML, Warnock DW (ed), Manual of 
Clinical Microbiology, 10th ed, vol 2. ASM Press, Washi ngton, DC, 2011.
 ● CLSI. Physician and Nonphysician Provider-Performed Microscopy Testing; Approved Guideline-
Second Edition. CLSI document POCT10-A2, Vol. 31 No. 24. Wayne, PA: Clinical and Laboratory 




A wet mount is a microscopic procedure performed to examine material collected from a 
specimen suspended in a drop of liquid on a glass slide. A wet mount is used to view cells and 
organisms for motility, morphological characteristics and identification. Specifically, it is used for 
the presence or absence of bacteria, fungi, parasites, and human cellular elements.
Specimen Collection
Prior to collecting specimens, perform hand hygiene and put on gloves. Standard precautions 
should be taken when collecting and handling blood or body fluid specimens. 
1. Collect a sampling of material with a sterile cotton swab passed through and along the area of 
concern.
2. For vaginal specimens, test the specimen for pH and document before adding to tube, 
if needed. Note: a pH greater than 4.5 is generally associated with bacterial vaginosis or 
trichomoniasis.
3. Place the swabs in a clean test tube containing 0.5 ml of normal (0.9%) saline. (Note: Ensure 
that the specimen tube has at least 0.5 ml of saline and no more than 1.0 ml which may affect 
quantification criteria based on your laboratory’s procedure.)
4. Label the tube with patient identifiers, date, and time of collection.
5. Gently twist the swabs in saline to dislodge particles from the swab tip.
6. Reseal the tube to preserve the specimen.
7. Do not refrigerate the specimens.
8. Perform testing immediately or transport to the laboratory for testing as soon as possible.
9. Examine the specimens within two hours of collection.
Wet Mount Slide Preparation
1. Label a clean microscope slide with specimen identification.
2. Using a sterile transfer pipette or dropper, gently mix the specimen with the pipette.
3. Remove a specimen from the tube and place one drop (10 μl) on the labeled microscope slide.
4. Immediately put a coverslip over the specimen for examination.
5. Examine the slide to verify that it is not overfilled and leaking once the cover slip is in place.
Wet Mount Microscopic Examination
1. Place slide on microscope for examination.
2. Focus using low power (10X) and low light.
3. Scan the entire slide.
4. Identify objects using high power (40X).
5. Read at least 10 fields using an “S” shaped viewing pattern.
6. Record findings.
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Common Wet Mount Microscopic Findings 
Trichomonas vaginalis
Trichomoniasis is a sexually transmitted infection caused by the parasite Trichomonas vaginalis, 
a motile pear-shaped protozoan. Trichomoniasis causes a vaginal discharge that is yellow-green, 




Bacterial vaginitis is often associated with a thin, gray-white or milky vaginal discharge adhering 
to the vaginal wall to give a fishy smell. Bacterial vaginitis is caused by high concentrations of 
Gardnerella vaginalis, Mycoplasma hominis and anaerobic bacteria such as Prevotella sp. and 
Mobiluncus sp. In the images below, the arrows indicate examples of bacteria.
  
Clue Cells
Clue cells are epithelial cells of the vaginal wall. They often appear fuzzy, lacking distinct sharp 
borders due to being covered with bacteria. Clue cells are a sign of bacterial vaginosis caused by 
high concentrations of Gardnerella vaginalis, Mycoplasma hominis and anaerobic bacteria such as 




Yeast are unicellular fungi that appear commonly in vaginal discharge wet mounts. Yeast can 
appear as budding yeast or yeast with pseudohyphae, an elongated filament-like string of 
attached cells. In the images below, the arrows indicate examples of yeast.
  
Squamous Epithelial Cells 
The majority of cells observed in a normal vaginal wet prep will be vaginal epithelial cells. 
Squamous epithelial cells are large and flat with an irregular shape, distinct borders, and a single 
nucleus. In the images below, the arrows indicate examples of squamous epithelial cells. 
  
White Blood Cells
White blood cells (WBCs) are a normal component of vaginal flora. WBCs are small and have a 
multi-lobed nucleus and appear dark and granular. WBCs can be elevated in infections involving 
Chlamydia, Trichomonas vaginitis, herpes, and Neisseria gonorrhoeae. A ratio of one WBC for 
every epithelial cell is considered within normal limits. In the images below, the arrows indicate 




The presence of red blood cells may indicate bleeding during the collection process. In the 
images below, the arrows indicate examples of red blood cells.
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PPM laboratories and testing sites use KOH preparations to detect the presence or absence of 
fungi in vaginal or thick mucoid specimens or in specimens containing keratinous material such 
as skin, hair, and nails. KOH digests cellular components of the host cells and other contaminants 
leaving the fungal cell wall intact allowing the fungal elements to be clearly observed. Fungal 
infections of the skin, hair, and nails are commonly caused by Tinea species, Trichophyton rubrum, 
and Candida albicans.
Specimen Collection
Prior to collecting specimens, perform hand hygiene and put on gloves. Standard precautions 
should be taken when collecting and handling blood or body fluid specimens. 
Vaginal Specimens
1. Collect vaginal specimens as described in the Wet Mount procedure section.
Skin Scrapings
1. Scrape the surface of the skin. Be careful not to contaminate scrapings with blood.
2. Place the skin scrapings between two clean glass slides or in a sterile container.
Hair
1. Collect at least 10–12 affected hairs with the base of the shaft attached.
2. Place in a sterile container. 
Nail Scrapings
1. Collect a nail clipping.
2. Place nail clipping in a collection packet or sterile glass slide.
3. Cut nail clipping into small fragments.
4. Scrape the excess keratin produced under the nail.
5. Place in a sterile container. 
KOH Slide Preparation
Vaginal Specimens 
1. Label a clean microscope slide with specimen identification.
2. Using a sterile transfer pipette or dropper, gently mix the specimen with the pipette.
3. Remove a specimen from the tube and place one drop (10 μl) on the labeled microscope slide.
4. Use a clean pipette and add one drop (10 μl) of 10% KOH directly on top of the specimen.
5. Check the slide for a “fishy”, amine odor and note presence or absence. The odor indicates 
anaerobic bacteria overgrowth.
6. Wait up to 5 minutes to allow cellular tissue and debris to dissolve.
7. Immediately put a coverslip over the specimen for examination.
8. Examine the slide to verify it is not overfilled and leaking once the cover slip is in place.
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Non-Vaginal Specimens 
1. Label a clean microscope slide with specimen identification.
2. Place the specimen on the slide and add one drop (10 μl) of 10% KOH directly on top of the 
specimen.
3. Wait up to 30 minutes to allow cellular tissue and debris to dissolve. Alternatively, the slide 
may be heated by placing the specimen slide on a heating block. 
Note: The exact time needed will depend on the thickness of the specimen fragments. Nail 
scrapings may require a 20% KOH solution.
4. Immediately put a coverslip over the specimen for examination.
5. Examine the slide to verify that it is not overfilled and leaking once the cover slip is in place.
KOH Preparation Microscopic Examination
1. Place slide on microscope for examination.
2. Focus using low power (10X) and low light.
3. Scan the entire slide.
4. Identify objects using high power (40X).
5. Read at least ten fields using an “S” shaped viewing pattern.
6. Record findings.
KOH Preparation Microscopic Findings
Yeasts are unicellular fungi that appear commonly in vaginal discharge wet mounts. Yeasts are 
larger than bacteria, approximately the size and shape of the nuclei of epithelial cells. Individual 
cells of yeast propagate by budding out similar cells from their surface. In PPM observations, 
yeasts are indicated by a loose arrangement of budding cells. In many fungi, the budding cells 
remain attached to the parent cell resulting in an elongated filament-like string of attached 
cells, pseudohyphae, with a cell budding off the tubular structure. In the images below, the 








A pinworm examination is used to determine the presence or absence of the parasite Enterobius 
vermicularis. The adult female worm migrates out of the anus, usually at night, and deposits her 
eggs on the perianal area. PPM testing includes the collection of a specimen from the skin in the 
perianal area followed by microscopic examination to detect the presence of the pinworm eggs. 
Pinworm Specimen Collection and Slide Preparation
Prior to collecting specimens, perform hand hygiene and put on gloves. Standard precautions 
should be taken when collecting and handling blood or body fluid specimens. Specimens should 
be taken early in the morning before bathing or use of the toilet. 
Paddle Method
1. Hold paddle by the cap and remove from tube.
2. Press sticky surface to the right and left perianal folds.
3. Replace the paddle in the tube until microscopic examination.
4. Place the paddle on a microscope slide labeled with patient identifiers.
Cellulose Tape Method
1. Apply a strip of clear cellulose tape to the anal folds.
2. Place tape sticky side down on a microscope slide labeled with patient identifiers. 
Note: Visibility of eggs can be improved by lifting the tape from the slide, adding a drop of xylene 
or toluene, and pressing down the tape back on the slide. This helps clear the preparation, and the 
eggs can be observed clearly.
Pinworm Microscopic Examination
1. Place slide on microscope for examination.
2. Focus using low power (10X) and low light.
3. Scan the entire slide.
4. Identify objects using high power (40X).
5. Read at least 10 fields using an “S” shaped viewing pattern.
6. Record findings.
Pinworm Preparation Microscopic Findings
E. vermicularis (pinworm) eggs are football-shaped, flattened on one side with a thick colorless 
shell. The eggs are approximately 70–85 by 20–23 μm, and may contain larva. Movement of the 





The Fern Test is used to detect amniotic fluid leakage from the membrane surrounding the fetus 
during pregnancy. If rupture of the membrane has occurred evidence of amniotic fluid will be 
present. Amniotic fluid will crystallize when dried on a glass slide forming a fern pattern due 
to relative concentrations of sodium chloride, proteins, and carbohydrates in the fluid. Normal 
vaginal secretions that do not contain amniotic fluid will not show the ferning pattern. The Fern 
Test may also be used for monitoring fertility. Cervical mucus smears form a fern pattern when 
estrogen secretion is elevated. 
Vaginal Specimen Collection
Prior to collecting specimens, perform hand hygiene and put on gloves. Standard precautions 
should be taken when collecting and handling blood or body fluid specimens. 
1. Collect a vaginal secretion with a sterile cotton swab from the posterior vaginal pool during 
the sterile speculum exam. 
2. Collect a sample from the external cervical os if pool of fluid is not evident.
Fern Test Slide Preparation
1. Label a clean microscope slide with specimen identification.
2. Roll the swab across the glass slide while applying pressure to express the fluid and creating  
a thin smear immediately after collection.
3. Allow slide to completely air dry (3–5 minutes).
4. Do not heat the slide or apply a coverslip.
Fern Test Microscopic Examination
1. Place slide on microscope for examination.
2. Focus using low power (10X) and low light.
3. Scan the entire slide.
4. Identify evidence of fernlike pattern.
5. Observe slide using high power (40X) to confirm ferning pattern.
6. Examine the entire slide using an “S” shaped viewing pattern.
7. Record findings.
Fern Test Microscopic Findings
Visualization of a characteristic ferning pattern may provide evidence membrane rupture. In the 




POST-COITAL DIRECT, QUALITATIVE EXAMINATION OF 
VAGINAL OR CERVICAL MUCUS
The post-coital test involves direct, qualitative examination of vaginal or cervical mucus to evaluate 
factors that could affect fertility. The test involves the qualitative analysis of the mucus including 
color, viscosity, and tenacity and the determination of the presence and motility of sperm. The 
assessment provides information to determine the receptivity of cervical mucus and the ability of 
sperm to penetrate the mucus. 
Patient Preparation
1. Patients should use an ovulation determination method.
2. When ovulation is detected, the patient and her partner should have intercourse.
3. Patient should remain in bed 10 to 15 minutes following intercourse to allow the semen to 
contact the cervical mucus.
4. Testing should be performed within 2–12 hours following intercourse.
5. Upon arrival for testing, provider should record time since intercourse.
Post-Coital Direct, Qualitative Examination of Vaginal or Cervical Mucus Slide 
Preparation 
Prior to collecting specimens, perform hand hygiene and put on gloves. Standard precautions 
should be taken when collecting and handling blood or body fluid specimens.  No lubrication 
should be used. 
1. Remove excess vaginal secretions with a sterile cotton swab during the sterile speculum exam 
to prevent contamination.
2. Remove cervical mucus using a suction device on the cervical os.
3. Test the specimen as soon as possible after collection.
Post-Coital Direct, Qualitative Examination of Vaginal or Cervical Mucus Procedure
Qualitative Analysis of Cervical Mucus
1. Determine the volume of mucus in the syringe. Alternatively, expel the mucus from the syringe 
into a sterile Petri dish and estimate the amount of mucus (scant, moderate, or profuse).
2. Record the color and clarity of the mucus. 
3. Label a clean microscope slide with specimen identification.
4. Remove a specimen from the Petri dish and place one drop (10 μl) on the labeled  
microscope slide.
5. Immediately put a coverslip over the specimen.
6. Pull the glass coverslip off of the glass slide. 
7. Determine the distance a thread of mucus remains attached to the glass slide when lifted. 
Alternatively, place a drop of mucus on a microscope slide and test tenacity by grasping a 
portion of the mucus with forceps and noting the distance which it can be drawn without 
breaking.
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Determination of Sperm Presence and Motility
1. Label a clean microscope slide with specimen identification.
2. Remove a specimen from the Petri dish and place one drop (10 μl) on the labeled  
microscope slide. 
3. Immediately put a coverslip over the specimen.
4. Examine the slide immediately to prevent drying of the specimen which may result in  
killing active spermatozoa.
5. Place slide under the microscope for examination.
6. Focus using low power (10X) and low light.
7. Observe slide using high power (40X).
8. Examine the entire slide using an “S” shaped viewing pattern.
9. Record the number and motility of sperm for each high powered field.
Post-Coital Direct, Qualitative Examination of Vaginal or Cervical Mucus Findings
Normal mid-cycle mucus should be clear, with minimal viscosity, and profuse. A tenacity 
measurement of 6 to 10 cm is desirable. The normal number of sperm in a post-coital examination 





Urine sediment examination is used for the detection and identification of formed elements in the 
urine. The test involves the collection of urine and microscopic examination of the urine sediment 
for formed elements such as cells, casts, crystals, and microorganisms. Specimens not obtained by 
“clean catch” methods often contain elements from other sources other than the urinary tract. The 
microscopic examination is a valuable diagnostic tool for the detection of renal and urinary tract 
disorders. 
Patient Preparation
1. Provide patients with instructions on how to perform a clean-catch urine specimen collection.
Urine Specimen Collection and Processing
Prior to collecting specimens, perform hand hygiene and put on gloves. Standard precautions 
should be taken when collecting and handling blood or body fluid specimens. 
1. Label a clean, dry container free of lint and debris with patient identifiers, date, and time of 
collection.
2. Obtain a midstream, clean-catch urine specimen. Concentrated first morning specimens are 
preferred.
3. Examine the specimen within 2 hours of collection or 4 hours if refrigerated. Otherwise, 
bacteria may proliferate, casts and crystals may dissolve, and particulate matter may settle out.
4. Place 12–15 ml of urine in a conical centrifuge tube labeled with the patient identifiers.
5. Centrifuge at 400 x g for 5 minutes. To prevent re-suspension of urine sediment, do not apply 
brake at the end of centrifugation. Higher centrifugation rates and longer centrifugation times 
may result in denigration of cellular casts.
6. Decant the supernatant carefully into a biohazard-designated sink or receptacle leaving 
approximately 1 ml in the tube.
7. Resuspend the sediment by gently tapping the bottom of the tube or using a pipet to mix.
Urine Sediment Microscope Slide Preparation
1. Label a clean microscope slide with specimen identification.
2. Using a sterile transfer pipette or dropper, gently mix the specimen.
3. Remove specimen from the tube and place one drop (10 μl) on the labeled microscope slide.
4. Immediately put a coverslip over the specimen for examination.
5. Allow urine to settle for 30–60 seconds before examination
6. Examine the slide to verify that it is not overfilled and leaking once the cover slip is in place.
Urine Sediment Microscopic Examination
1. Place slide under the microscope for examination.
2. Focus using low power (10X) and low light.
3. Scan the entire slide.
4. Read at least 10 fields using an “S” shaped viewing pattern.
5. Record the presence of crystals, casts, and squamous epithelial cells using semi-quantitative 
terms such as rare, few, moderate, or many and report results following laboratory procedure.
6. Identify objects using high power (40X).
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7. Record the presence of red blood cells, white blood cells, and renal tubular cells. Quantitate 
the average number of elements per high power field and report results following laboratory 
procedure.
8. Note the presence of bacteria, yeast, trichomonads, and mucus.
Common Urine Sediment Microscopic Findings
Visualization of a characteristic ferning pattern may provide evidence membrane rupture. In the 
images below, the arrows indicate examples of positive ferning.
Casts
Urinary casts are small cylindrical structures that can be found in urine. Casts are formed by the 
solidification of proteins in the lumen of the kidney tubules and vary in size and shape according 
to the tubules where they were formed. The presence of casts in urine is associated with various 
pathologic conditions such as glomerular or tubular damage, renal inflammation or infection.
 
Hyaline casts are the most frequently seen urinary casts and 
a few may be seen in healthy individuals. They have a smooth 
texture and their refractive index is close to that of their 
surroundings. Increased numbers of hyaline casts are usually 
caused by dehydration, exercise, or diuretic medicines and may 
be associated with some renal diseases. An example of a hyaline 
cast is indicated by the arrow.
 
Granular casts may be course to fine in appearance. Granular 
casts are a sign of many types of kidney diseases and may often 
indicate significant renal disease. An example of a granular cast 
is indicated by the arrows.
 
Fatty casts contain refractile liquid droplets within the cast. 
Fatty casts are seen in people who have lipids in urine, usually as 
a complication of nephrotic syndrome and diabetes mellitus. An 




Red blood cell casts are granular cylinders composed of a 
matrix of red cells in various stages of degradation. Red blood 
cell casts are indicative of bleeding into the kidney and may be 
present in many kidney diseases such as glomerulonephritis 
or vasculitis. Red blood cell casts may also be present in lupus 
nephritis, Goodpasture syndrome, and subacute bacterial 
endocarditis. An example of a red blood cell cast is indicated by 
the arrow.
 
White blood cell casts contain leukocytes in the cast matrix. 
White blood cell casts are common with acute kidney infections 
and may be present in renal infection, glomerular disease, 
pyenlonephritis and interstitial nephritis. Examples of white 
blood cell casts are indicated by the arrows.
 
Renal tubular epithelial cell casts contain renal tubular 
epithelial cells in the cast matrix. Individual cells may appear 
randomly in or they can align as fragments of the tubular lining 
within the cast. These casts are seen in conditions such as renal 
tubular necrosis, viral disease (such as CMV nephritis), and 
kidney transplant rejection. Examples of renal tubular epithelial 
cell casts are indicated by the arrow.
 
Waxy casts have smooth edges with squared off ends and do 
not have inclusions present. Waxy casts can be found in persons 
with advanced kidney disease and chronic kidney failure. An 
example of a waxy cast is indicated by the arrow.
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Crystals
The presence of trace crystals in urine is often of no clinical significance in healthy individuals. 
The presence of a large number of crystals may indicate underlying health issues. It is import 
to differentiate between crystals frequently found in the urine and abnormal crystals whose 
appearance is pathological. The pH of fresh urine aids in the identification of crystals. Crystals 
found in the urine at an alkaline pH are usually considered normal. Abnormal crystals precipitate  
in the urine at an acidic pH. Other biochemical tests may be needed to confirm the identification 
of abnormal crystals. 
Alkaline Crystals
 
Triple phosphate crystals are colorless with a “coffin-lid” 
appearance. Although considered normal, they may be 
associated with urinary tract infections when found in freshly 
voided morning specimens. An examples of a triple phosphate 
crystal is indicated by the arrow.
 
 
Calcium phosphate crystals are large wedge-shaped prisms 
that may appear as rosettes. They may be associated with kidney 
stone formation. Examples of calcium phosphate crystals are 
indicated by the arrows.
 
 
Ammonium biurate crystals often appear as a “thorn apple” 
shape. The presence of these crystals in urine with a pH 9.0 
or higher usually indicates an old specimen. Examples of 
ammonium biurate crystals are indicated by the arrows.
 
 
Calcium carbonate crystals appear as small, colorless, and 
dumbbell shaped. When dissolved in acetic acid, these crystals 
give off bubbles of gas (effervesce). Examples of calcium 





Uric acid crystals vary in size and shape and are often yellow-
brown in color. They may be associated with kidney stone 
formation. Uric acid crystals are often seen in patients with Gout, 
Lesch-Nyhan syndrome, and leukemia. Examples of uric acid 
crystals are indicated by the arrows.
 
 
Calcium oxalate crystals are colorless and appear in many 
forms. The dihydrate form appears “envelope shaped” with a 
highly refractile cross connecting the corners. The monohydrate 
form can appear as dumbbell, ovoid, or rectangular in shape. 
Calcium oxalate crystals are associated with kidney failure 
due to ethylene glycol (antifreeze) poisoning. Examples of the 




Bilirubin crystals appear as yellow-brown needles or granules. 
These crystals are considered abnormal in urine and may be 
associated with several hepatic disorders. An example of a 
bilirubin crystal is indicated by the arrow.
 
 
Cystine crystals appear as colorless, hexagonal plates. These 
crystals are considered abnormal in urine may be associated 
with cystinuria. Cystine crystals are a frequent cause of kidney 




Tyrosine crystals appear as colorless to yellow-brown needles 
arranged in radiating sheaves. These crystals are considered 
abnormal in urine and may be seen in tyrosinemia and in 
some liver disorders when there is impairment to amino acid 






Leucine crystals appear as yellow-brown needles or granules. 
These crystals are considered abnormal in urine and may be 
associated with several hepatic disorders. An example of a 
leucine crystal is indicated by the arrow.
 
 
Cholesterol crystals appear as clear, flat plates with notched 
corners. These crystals are considered abnormal in urine and 
may be associated with nephrotic syndrome. Examples of 
cholesterol crystals are indicated by the arrows.
 
 
Sulfonamide crystals have a varied appearance including flat 
needles, sheaves of small needles, and spheres. These crystals 
are considered abnormal in urine and may indicate presence of 
a sulfonamide drug and may be associated with kidney stone 




Radiopaque dye crystals appear as flat needles. These crystals 
are considered abnormal in urine and are associated with very 
high specific gravity results by refractometry. Examples of 






The presence of mucus threads is often a benign situation. Large 
amounts of mucus in the urine most often indicates a urinary 
tract infection but may also be associated with irritable bowel 
syndrome, kidney stones, and some cases of malignant tumors 




Red Blood Cells 
In fresh urine, normal red blood cells appear as biconcave discs 
with distinct, dark, smooth cell walls. Red blood cells may be 
present in less than 5 cells per high power field in normal urine. 
In hypotonic urine, the red blood cells swell and lyse resulting in 
cells that appear as an empty shell. In hypertonic urine, the red 
blood cells crenate and form jagged cell walls. High red blood 
cell counts are associated with urinary tract disease such as 




White Blood Cells 
The presence of up to five white blood cells per high powered 
field may be seen in normal urine. High neutrophil counts 
suggest inflammation or infection within the urinary tract. 
Examples of white blood cells are indicated by the arrows.
 
 
Renal Tubular Epithelial Cells 
Renal tubular epithelial cells are large and have a distinct single 
round nucleus. The presence of more than 15 renal tubular 
epithelial cells per high power field may be indicative of renal 
disease or tubular injury. Examples of renal tubular epithelial 




Squamous epithelial cells (indicated by “A” in the image) are 
flat with an irregular border. A large number of squamous 
epithelial cells present may indicate a contaminated specimen. 
Transitional epithelial cells (indicated by “B” in the image) from 
the skin surface or from the outer urethra can appear in normal 







The presence of bacteria in urine usually indicates a 
contaminated specimen and is of little significance except in 
fresh catheterized specimens. The presence of high numbers 
of one organism with a high white blood cell count may be 
indicative of a urinary tract infection. The presence of bacteria 





The presence of yeast in urine sediment of females is often a 
result of vaginal contamination from a yeast infection. Yeast is 
also associated with diabetes mellitus due to the presence of 




NASAL SMEAR FOR GRANULOCYTES
The examination of nasal smears for granulocytes is performed to detect eosinophils, a specific 
type of granulocyte, in nasal secretions as an indicator of allergic rhinitis. 
Nasal Specimen Collection
Prior to collecting specimens, perform hand hygiene and put on gloves. Standard precautions 
should be taken when collecting and handling blood or body fluid specimens.
1. Collect a nasal discharge specimen onto a nonabsorbent material such as plastic wrap or 
wax paper.
2. Transfer a sample of the collected mucus with a sterile cotton swab.
Alternatively,
1. Collect a nasal secretion with a sterile nasopharyngeal swab by passing gently through the 
nostril into the nasopharynx.
2. Rotate the swab applying gently pressure to obtain a sufficient amount of specimen.
3. Repeat the process using the same swab on the other nostril.
Nasal Smear Slide Preparation
1. Label a clean microscope slide with specimen identification.
2. Roll the swab gently across the glass slide while applying pressure to express the fluid and 
creating a thin smear immediately after collection.
3. Allow slide to completely air dry (3–5 minutes).
4. Do not heat the slide or apply a coverslip.
5. Stain the smear using either a commercially prepared Wright-Giemsa stain or a Hansel stain 
following the manufacturer’s procedure or documented laboratory procedures.
Nasal Smear for Granulocytes Microscopic Examination
1. Place slide on microscope for examination.
2. Focus using low power (10X) and low light.
3. Scan the entire slide.
4. Identify evidence of fernlike pattern.
5. Observe slide using high power (40X) to confirm ferning pattern.




Nasal Smear for Granulocytes Microscopic Findings
Eosinophils stain to show bright red or reddish orange granules in the cytoplasm, as indicated by 
the arrows in the images below. The presence of more than three eosinophils per high power field 




The fecal leukocyte examination is used to determine the presence of leukocytes in a fecal 
smear. Fecal leukocytes are indicators of bacterial infection such as shigellosis and can provide 
information to differentiate possible life threatening inflammatory diarrheas from non-
inflammatory diarrheas.
Fecal Specimen Collection
Prior to collecting specimens, perform hand hygiene and put on gloves. Standard precautions 
should be taken when collecting and handling blood or body fluid specimens.
1. Label a clean, dry container which is sealable and leak proof with patient identifiers, date,  
and time of collection.
2. Obtain a stool specimen free of urine.
3. Store at room temperature. Do not place the specimen in the refrigerator. 
Fecal Leukocyte Slide Preparation
1. Label a clean microscope slide with specimen identification.
2. Use an applicator stick to apply a small amount of stool to the slide.
3. Stain slide with commercially prepared Loeffler’s methylene blue or Wright-Giemsa stain 
following the manufacturer’s procedure or documented laboratory procedures.
4. Apply a coverslip.
Fecal Leukocyte Examination Microscopic Examination
1. Place slide on microscope for examination.
2. Focus using low power (10X) and low light.
3. Scan the entire slide.
4. Observe slide using high power (40X).
5. Examine the entire slide using an “S” shaped viewing pattern.
6. Record the presence of fecal leukocytes.
Fecal Leukocyte Examination Microscopic Findings
The presence of fecal leukocytes as indicated by the arrows in the images below may indicate 
bacterial inflammatory enteritis condition associated with infection by Salmonella, Shigella, 
invasive Escherichia coli, or Yersinia. Fecal leukocytes may also be associated with infection by 
Entamoeba histolytica. The presence of fecal leukocytes may be indicators of inflammatory bowel 
diseases such as ulcerative colitis and Crohn disease, and fecal neutrophils occasionally can be 





The qualitative semen analysis is limited to the determination of the presence/absence of 
sperm and sperm motility. Semen analysis may be performed to evaluate the effectiveness of 
a vasectomy procedure, evaluate infertility, or to determine the suitability of semen for use in 
artificial insemination.
Semen Specimen Collection
Prior to collecting specimens, perform hand hygiene and put on gloves. Standard precautions 
should be taken when collecting and handling blood or body fluid specimens.
1. Label a clean, dry container which is sealable and leak proof with patient identifiers, date,  
and time of collection.
2. Collect semen in container.
3. Evaluate the specimen within 30 minutes of collection.
4. Store at room temperature. Do not place the specimen in the refrigerator. Do not use 
specimens older than 2 hours.
Qualitative Semen Analysis Slide Preparation
1. Label a clean microscope slide with specimen identification.
2. Using a sterile transfer pipette or dropper, gently mix the specimen with the pipette.
3. Remove a specimen from the tube and place one drop (10 μl) on the labeled  
microscope slide.
4. Immediately put a coverslip over the specimen for examination.
5. Examine the slide to verify that it is not overfilled and leaking once the cover slip is in place.
Qualitative Semen Analysis Microscopic Examination
1. Place slide on microscope for examination.
2. Focus using low power (10X) and low light.
3. Observe slide using high power (40X).
4. Examine the entire slide using an “S” shaped viewing pattern.
5. Record the number and motility of sperm for each high powered field.
Qualitative Semen Analysis Microscopic Findings
The presence or absence of sperm is determined. In post-vasectomy patients, centrifugation 
of the specimen may be performed to assure a thorough analysis. The percent of motile sperm 
(sperm moving in forward direction) is calculated by examination of at least 100 spermatozoa. 





TERMS AND ABBREVIATIONS 
Biohazardous waste Biohazard or sharps waste and waste that is generated or produced as a results 
of the diagnosis, treatment, or immunization of humans. Environmental laws 
dictate appropriate, safe disposition of hazardous waste. Refer to applicable 
federal, state, and local laws. 
Biosafety The application of practices, procedures and safety equipment when working 
with infectious materials to prevent infection. 
Bloodborne pathogens Microorganisms that, when present in human blood, can cause disease in 
humans. Examples are hepatitis B and C viruses, and human immunodeficiency 
virus (HIV). 
CDC, The Centers for 
Disease Control and 
Prevention 
A federal agency under the department of Health and Human Services (HHS) 
that works with partners throughout the nation and world by collaborating to 
create the expertise, information, and tools that people and communities need to 
protect their health—through health promotion, prevention of disease, injury and 
disability, and preparedness for new health threats. 
CLIA, The Clinical 
Laboratory 
Improvement 
Amendments of 1988 
United States federal regulatory standards that set forth the conditions that all 
laboratories must meet to be certified to perform testing on human samples. 
CMS, The Centers for 
Medicare & Medicaid 





A certificate issued or reissued by the Centers for Medicare & Medicaid Services 
to laboratories or testing sites performing Provider-Performed Microscopy 
procedures, as well as any waived tests.
Certificate of Waiver A certificate issued or reissued by the Centers for Medicare & Medicaid Services 
to a testing site performing only waived tests. 
Compliance The act of adhering to, and demonstrating adherence to, a standard or regulation. 
Contamination The accidental introduction of “foreign” material that can seriously distort the 
results of experiments where small samples are used. 
Control A device or solution used to monitor a test system to ensure proper test 
performance and correct results. 
Corrective action A method used to remedy a situation, remove an error, adjust a condition, or 
prevent recurrence of a problem. 
Decontamination The removal or neutralization of toxic agents or the use of physical or chemical 
means to remove, inactivate, or destroy living organisms on a surface or item so 
that the organisms are no longer capable of transmitting infectious particles and 
the surface or item is rendered safe for handling, use, or disposal. 
Disinfectant An agent that destroys microorganisms that may cause disease. 
Engineering controls Controls (e.g., sharps containers, self-sheathing needles) that isolate or remove 
the bloodborne pathogens hazard from the workplace. 
Ergonomics The science of fitting workplace conditions and job demands to the capabilities of 
the working population. 
Exposure Contact with blood or other potentially infectious materials that result from the 
performance of an employee’s duties. 
External assessment A review that is typically performed by an outside party to evaluate current 
practices and offer opportunities for education. 
FDA, The Food and 
Drug Administration 
A federal agency under HHS that is responsible for regulating and supervising 
the safety of biological and medical products and devices as well as 
categorization of tests under CLIA, including waiver. 
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Good laboratory 
practices
A technique, method, process, or activity that is believed to be more effective 
at producing accurate and reliable laboratory testing than any other technique, 
method, or process. 
HHS, The Department 
of Health and Human 
Services 
The United States government’s principal agency for protecting the health of all 
Americans and providing essential human services. 
HIPAA, Health 
Insurance Portability 
and Accountability Act 
of 1996 
The Privacy Rule provides federal protections for personal health information 
held by covered entities and gives patients an array of rights with respect to that 
information. At the same time, the Privacy Rule is balanced so that it permits 
the disclosure of personal health information needed for patient care and other 
important purposes. 
Infectious materials Materials containing viable microorganisms including bacteria, viruses, 
parasites, or fungi  that are known or reasonably believed to cause disease  
in humans or animals.
Internal assessment A review that staff performing and overseeing testing perform to evaluate their 
current practices. The process of critical review of the laboratory. 
Manufacturer’s 
instructions 
Written product information usually supplied by the manufacturer with each test 




Reasonably anticipated skin, eyes, mucous membrane, or parenteral contact 
with blood or other potentially infectious materials that may result from the 
performance of an employee’s duties.
OSHA, The 
Occupational 
Safety and Health 
Administration 
The United States government agency with the mission to assure safe and 
healthful working conditions for all men and women. Workplace standards 
established and enforced to prevent work-related injuries, illnesses, and deaths 
by issuing and enforcing rules for workplace safety and health. 
Performance 
assessment 
The evaluation of a person’s ability to perform a test and to use a testing device; 
this includes all aspects of testing, from sample collection to results reporting. 
PPE, Personal 
protective equipment 
Specialized clothing or equipment worn by an employee for protection against a 




Provider-Performed Microscopy procedures are a select group of moderately 
complex microscopy tests commonly performed by health care providers during 
patient office visits.
Procedure A fixed, step-by-step sequence of activities or course of action (with definite  
start and end points) that must be followed in the same order to correctly  
perform a task. 
Processing (specimen) Any type of treatment a specimen undergoes before testing such as spinning  
of whole blood. 
PT, Proficiency testing An external quality assessment program in which samples are periodically sent 
to testing sites for analysis. Proficiency testing involves a group of laboratories 
or analysts performing the same analyses on the same samples and comparing 
results. The key requirements of such comparisons are that the samples 
are homogenous and stable, and also that the set of samples analyzed are 
appropriate to test and display similarities and differences in results.
QC, Quality control The procedures used to detect and correct errors that occur because of test 
system failure, adverse environmental conditions and variance in operator 
performance, as well as the monitoring of the accuracy and precision of the  
test performance over time. 
Quality assurance Part of quality management focused on providing confidence that quality 
requirements will be fulfilled.
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Sharps Instruments, tools, or items that have rigid, acute edges, protuberances or 
corners capable of cutting, piercing, ripping or puncturing such as syringes, 
blades, and broken glass. Items that have the potential for shattering or breaking 
are also considered sharps.
Specificity (analyte) The ability of a test to detect a particular substance or constituent without 
interference or false reactions by other substances.
Specimen A substance collected for analysis on the assumption that it represents the 
composition of the whole. 
Test system The instructions and all the instrumentation, reagents and supplies needed to 
perform a test and generate results. 
Testing site The location where testing is actually conducted. In some instances, laboratories 
do not stay at a fixed location (e.g., mobile units providing laboratory testing, 
health screening fairs, or other temporary testing locations). In these cases, the 
testing site for the laboratory is where the test is performed. 
Universal precautions An approach to infection control where all human blood and certain human body 
fluids are treated as if known to be infectious for HIV, HBV, and other bacteria  
and viruses. 
Waived testing Test systems, assays or examinations that have been cleared by the FDA for 
home use, or have been determined to meet the CLIA criteria of being a simple 
test with an insignificant risk for an erroneous result. 
For additional information go to: http://wwwn.cdc.gov/clia/Resources/PPMP
Contact the Division of Laboratory Systems at PPMP@cdc.gov or by calling 404-498-2290.
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